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 Abstract 
Four variables from the HBM of healthcare behavior were used to examine immunization 
decision making by the lay public.  Although there was evidence to support the HBM in general, 
results of these studies suggest that up to 70% of the variance in immunization decision-making 
could be explained by disease base rates alone.  When there is a main effect of immunization 
side effects, this effect was entirely within the most severe category of side effect.  In initial four 
experiments, there was a consistent interaction between the variable of disease type and the 
variables of disease severity and immunization side effects.  The fifth experiment showed an 
interaction between disease type and immunization efficacy.  Functional measurement was used 
to examine the nature of the interaction between the variables of disease base rates and 
immunization efficacy.  This interaction is neither clearly additive nor multiplicative.  Disease 
base rate dominates the other variables, although each modifies immunization likelihood 
somewhat in interaction with disease base rates.  Furthermore, results suggest that participants 
did not appear to react to the difference between different disease base rates when the 
probabilities are small.  Participants also did not conceptualize immunization efficacy as a 
conditional probability.  Suggestions for how to address these issues via decision support were 
made.  The principle contribution of this study, however, is development of a methodology.  The 
method developed here investigates the variables of the HBM in an ecologically valid factorial 
design.  This approach takes the HBM beyond description of variables to provision of prediction 
and generalizable results.
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CHAPTER 1 -  Introduction 
“The (Salk polio) vaccine was instrumental in the near eradication of a once widely-
feared disease.”  Wikipedia (2006) 
 
“Our children face the possibility of death or serious long-term adverse effects from 
mandated vaccines that aren’t necessary….” Jane M. Orient, MD, AAPS Executive Director. 
Vaccineinfo.net web site (22 August 2006) 
 
The subject of the research to be discussed here is immunization decision making. The 
above quotes capture the range of views about immunization and suggest why decision making 
in this area is difficult.  In an article in The New York Times on how Americans view disease, 
Fountain (Jan 15, 2006) notes that people seem to view rare and unfamiliar diseases as more 
harmful than common and familiar ones.  This style of risk assessment may influence 
immunization decision-making.  Healthcare personnel have long puzzled over the disparity 
between risk of infectious disease as assessed by healthcare providers and disease prevention 
behavior, such as immunizations, as practiced by the public.    
At one time, people were termed non-compliant when their health practice behavior was 
counter to recommendations made by their physicians.  However, more recently, the medical 
community has come to recognize that individuals may make healthcare decisions by weighting 
variables differently than do healthcare providers (Lerner, 2006).  There are many approaches to 
studying the issue including surveys of variables affecting immunization decisions made by the 
lay public and by medical personnel, and experimental decision-making research.  The present 
research is in the tradition of decision-making research and will focus on decisions about 
immunization acceptance.    
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What is known from the healthcare literature will be reviewed first.  The HBM (HBM), 
identified in the early 1950s by social psychologists (Rosenstock, 1974) best describes this 
research.  The HBM suggests that two disease factors, disease severity and disease likelihood, 
and two immunization factors, immunization effectiveness and immunization side effects, are 
likely to influence immunization acceptance by the general public.  Surveys based on the HBM 
interpret the model in different ways and draw varied conclusions about the implications of the 
survey findings.  This research will be discussed in Chapter 2.   
Decision-making research models from cognitive psychology, including Expected Utility 
and Subjective Expected Utility (Edwards, 1961) and Heuristics and Biases (Tversky & 
Kahneman, 1974), the Lens Model (Hammond, 2000), and the cognitive tools school of thought 
(Gigerenzer & Selten, 2002) will be discussed in Chapter 3.  Research on risky decision-making 
shows that the framing of information is important to decision-making.  Mathematical 
equivalence of two alternatives while stating the decision in different frames of reference for 
each alternative is the hallmark of framing effects research.  Although much of the heuristics and 
biases literature focuses on irrationality, Frisch (1993) suggested that the decisions evoked by 
different frames of reference can be quite rational.   In addition, much of this research is highly 
artificial.   
Hammond, Stewart and Behmer, et al. (1986) discuss a partial solution to these problems.  
They maintain that stimuli used in decision-making research should reflect those in the 
environment.  Hammond (2000) maintains that the question asked is not what is the correct 
decision, but rather what the does the participant do in response to specific environmental cues.  
He refers to Brunswick’s ideas of the matching of cues in the experiment to those in the 
environment “ecological validity” or a “representative design” (Hammond, Stewart & Behmer, 
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et al., 1986, p 61). However, Hammond’s approach is limited because of a belief that achieving 
ecological validity precludes a factorial approach to investigation of these phenomena.  The 
present research attempted to construct an ecologically valid design so that the variables in the 
HBM could be examined systematically. 
Context issues were studied initially in an effort to identify how the HBM variables 
should be represented.  There are numerous extraneous variables, such as how the information is 
presented, that may impact the problem.  This makes the immunization decision complex.  Using 
the four variables identified in the HBM, five studies were conducted to identify how some of 
these extraneous variables affect response to the variables of the HBM.   
Initial experiments, discussed in Chapter 4, address the issues of framing the decision as 
risk/risk or as a risk/benefit trade off, the effect of presenting likelihood information as 
probability statements or as frequency statements, and the effect of naming a disease or just 
referring to the disease generically as “a disease”.  All of these variables could be thought of as 
context variables.  Establishing their influence on immunization decisions was an important 
design issue.   The general pattern of response across all experiments was the same.  Response 
appeared to reflect the probabilities associated with each of the diseases used for the 
experimental stimuli. 
Immunization for each disease has a given efficacy.  Immunization efficacy had been 
held constant for each disease used in the initial experiment.  Therefore, a fourth experiment 
specifically examined the effect of shot efficacy, on immunization decision-making by 
systematically manipulating this variable.  Manipulation of this variable does not detract from 
the ecological validity of the experimental design because there is a range of efficacies for 
immunizations.   
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There were persistent effects of disease type across all initial experiments and significant 
interactions with the other variables.  Therefore, another experiment examined the nature of the 
interaction of the disease variable with one of the other variables, shot efficacy.  This study used 
the findings from the initial studies to examine how immunization information is integrated to 
form a decision.  The methodology for this study was based on Information Integration Theory 
(Anderson, 1974). 
Functional Measurement (Anderson, 1974) is an approach to cognitive psychology that 
models how information is cognitively integrated to form decisions on which behavior is based.  
Functional measurement analyzes data at both group and individual levels, since there may be 
important variation in how individuals integrate information that is missed when data is only 
examined at the group level.  Functional measurement is discussed in Chapter 5. 
Chapter 6 discusses the design for the final study.  The problem is decomposed to the 
level of disease base rates and immunization effectiveness in order to carefully examine the 
interaction of these two variables.  These two variables were shown in the earlier studies to be 
important to the immunization decision.   
Simplifying the design to focus on two variables enables the investigator to examine how 
participants integrate information on these two variables to form a decision.  Ecologically valid 
stimuli were selected based on the initial experiments, review of the medical literature, and 
consultation with medical personnel. This leads to a 3x4 factorial design which systematically 
varied probabilities for disease base rate and immunization effectiveness. The use of ecologically 
valid cues for the stimuli increases the likelihood that finding from this study would be replicable 
and would generalize to other situations.   
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Results of the information integration study are discussed in Chapter 7.  The effects of 
various manipulations in the design are discussed along with learning effects.   Across all 
studies, it was found that disease base rates explained more of the variance than any other HBM 
variable.  However, the existence of a significant interaction and some residual effects suggests 
that there may be a more complex picture of integration that should be further studied.  In 
addition, participants appear not to notice small differences in disease base rates and to be unable 
to recognize immunization efficacy as a variable that is contingent on disease base rates.  
Limitations are discussed in Chapter 8.  The most important limitation to this study is that 
participants are in a laboratory setting and are asked to place themselves into a hypothesized 
immunization situation.  Therefore, decisions made in this setting are hypothetical.  However, 
due to careful selection of stimuli and their presentation, findings are likely to be of value in 
understanding immunization decision-making. 
Chapter 9 discusses the results and future directions suggested by these results.  The 
ability to develop ecologically meaningful stimuli for use in a controlled laboratory experiment 
is an important methodological contribution of this study.  With this approach, the key question 
of how much difference between stimulus values for each of the variables in the HBM is 
noticeable enough to change behavior can be systematically examined.  Further, quantifying 
responses to different variables in the HBM can lead to a better understanding of immunization 
behavior and further refinement of the model.   
One important contribution is demonstration that a disease base rate contributes a large 
amount to the variance in behavioral response.  This suggests ways in which healthcare 
personnel might approach patient education.  In addition, findings from this study can be used to 
design decision support programs for patients, putting variables in contexts that are meaningful 
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to the patient.  Finally, the methodology developed in this series of studies can be used to 
examine other consequential healthcare decisions, such as use of medication or treatment follow 
through for such diseases as diabetes, hypertension and cancer. 
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CHAPTER 2 -  The HBM of Immunization Decision Making: 
Literature Review 
Acceptance of adult immunization against Influenza and acceptance of childhood 
immunization by parents are the two immunization behaviors most studied by healthcare 
providers.  There have also been a few studies of cultural/family differences immunization 
acceptance.  The field of health risk communication has conducted studies on how risk 
communication influences immunization behavior.  Most of this research uses some form of the 
Health Beliefs Model (HBM) (Becker, 1974) as a theoretical frame of reference.  This chapter 
will review what is known from healthcare research about factors influencing immunization 
behavior 
The HBM (Becker, 1974) originated from a series of studies in the 1950s focused on 
answering the question: Why do healthy people sometimes decline to use preventive medicine 
behaviors aimed at maintaining health?  The model posited four beliefs regarding preventive 
medical behavior:  1. A belief that one is susceptible to a given disease, 2. Belief that, if the 
disease were contracted, it would severely affect life, 3. Belief that specific action would be 
effective in preventing or reducing the effect of the disease and   4.  Belief that preventive action 
would not entail severe barriers as in terms of cost, pain, embarrassment or difficulty.   However, 
Rosenthal (1974) points out that there is no evidence that targeting any one component of the 
HBM will have a reliable and predictable effect on people. 
Five studies addressing influenza immunization among the elderly represent the literature 
on influenza.  Each study used a different design and method of analysis, but all were survey 
studies and all addressed beliefs about influenza and immunization.   
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Nexae, Kragstrup and Sogaard (1999) conducted a questionnaire study assessing general 
health, locus of control and beliefs about health in the fall, prior to the onset of influenza’s 
seasonal onset.  They then followed up with a second questionnaire in mid-winter, asking 
whether or not participants had obtained a flu shot.  Participants who acknowledged poor health 
and/or reported that they had a chronic disease requiring medications were classed as “high risk” 
for complications from influenza.  These are the people healthcare providers target for influenza 
campaigns.  Health beliefs were assessed by questions based on but not exactly like the HBM.   
The survey used by Nexae, Kragstrup and Sogaard (1999) included three of the 
dimensions based on the HBM: (1) perceived benefits, (2) perceived susceptibility, and (3) 
perceived severity.  It also assessed perceived barriers, which they included in their interpretation 
of the HBM.  Locus of control was also assessed.  They found that vaccination rates, even among 
people in high-risk groups were low (just slightly over 50%).  Although more people in the high-
risk group were vaccinated than those in the lower risk groups, the belief that one was in a high-
risk group did not predict vaccination.  They concluded that their HBM did predict vaccination 
behavior, while the Locus of Control Scale did not predict vaccination.    
Telford and Rogers (2003) interviewed elderly patients, ten of whom had accepted 
recommended influenza vaccination and ten of whom had refused the recommended vaccination.  
They found that subjective assessment of risk was a key factor in influencing immunization 
acceptance.  Subjective reports of those who accepted immunization reflected trust in modern 
medicine, social networks, and personal experience.   These beliefs were thought to reflect 
vaccination effectiveness and perception of personal risk of disease.  Those who refused 
vaccination reported mistrust of modern medicine, social network, and personal experience with 
adverse effects or ineffectiveness of vaccine and perception of little vulnerability to disease.  
  
9
These subjective beliefs appeared to influence vaccination decisions independently of risks and 
benefits assessed by the medical community.  These finding are qualitatively compatible with the 
HBM described by Rosenstock, (1974) in that these elderly patients described a belief (or 
disbelief) in vulnerability to disease and belief (or disbelief) in effectiveness of immunization as 
motivating immunization decisions.  However, this survey included several other factors, such as 
trust in modern medicine that are extensions of the HBM. 
A study by Gene, et al. (1992) was similar to that done by Telford and Rogers (2003).  
This study focused on patients who were identified by healthcare providers as high risk for 
complications from the flu.  As in the Nexae, Kragstrup and Sogaard (1999) study, this 
investigation surveyed patients prior to the flu season, then assessed immunization behavior 
toward the end of the flu season.  This study found that belief that one is vulnerable to influenza, 
regardless of vulnerability assessed by medical personnel, was a key factor in predicting 
immunization behavior.   However, many patients assessed as “high risk” by their healthcare 
provider did not assess themselves as high risk.  In addition, patients who did not accept 
immunization reported a belief that the immunization was not effective.  This study also 
identified the belief that the healthcare provider was providing adequate care as influential in 
immunization decision making.  As in other studies, these findings were interpreted as 
compatible with the HBM. 
A study by Bekker, Gough and Williams (2003) targeted people ages 65+, those who are 
more vulnerable to side effects from influenza.  This survey found that people who refused 
immunization were not only likely to believe that immunization was not effective against the flu, 
but also were more likely to believe that immunization could actually cause the flu and that 
healthcare providers were not supportive of immunization.  These results, while not inconsistent 
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with some variables of the HBM, go beyond that model to include other beliefs as well.  
However, results are interpreted as reflecting the HBM. 
Thus, four surveys of patients at high risk for complications from influenza found that 
health beliefs were important factors in predicting immunization.  Each study interprets the HBM 
differently.  Each study suggested a different approach to influencing these beliefs.  One study 
(Nexae, Kragstrup & Sogaard,1999)  suggested that free vaccinations and advice from general 
practitioners would increase vaccination acceptance.  One study (Gene, Espinola, Cabezas, et al., 
1992) suggested that health education focused on influenza and directly targeting high-risk 
recipients would increase immunization acceptance. Two studies (Telford & Rogers, 2003; 
Bekker, Gough & Williams, 2003) each suggested addressing beliefs, but methods and focus 
were slightly different.  Bekker, Gough and Williams (2003) argue that beliefs about 
immunization effectiveness and likelihood of side effect from immunization should be directly 
addressed in information campaigns.  In addition, they believe communication showing that 
immunization acceptance is a positive social norm should be part of the immunization message.  
Telford and Rogers (2003) focused more on changing the perception of immunization messages 
as directive and using a generic approach (as opposed to taking personal views and experiences 
into consideration) would make people more likely to accept immunization. 
Two studies specifically examined influences on parents making decisions for their 
children.  New and Senior (1991) asked parents about immunization of their infants.  They found 
that parental decisions were based on experience with immunization, advice from friends and 
relatives, as well as from healthcare providers and on accessibility to healthcare.  They suggest 
that these factors interact to influence behavior. 
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Sporton and Francis (2001) studied the decision making of parents who had chosen not to 
have their children immunized.  Parents who refuse to have their children immunized universally 
focus on risk of side effects.  Health professionals were seen as not providing balanced 
information directly discussing the pros and cons of immunization.  They recommended that 
information against immunization as well as for immunization be presented and the parents 
encouraged to discuss the decision with their healthcare provider. 
As noted in some of the studies above, family and friends are influential in immunization 
decisions.  These influences were examined specifically in two studies.  In a case controlled 
survey study of patients older than 65, Takahasu, et al. (2003) identified family and close friends 
as influential in patient’s decisions about accepting influenza vaccination.  They suggested that, 
for some cultures, e.g. Asian and Hispanic, family opinion is a critical consideration in decision 
making for oneself.  As in previous studies cited above, belief in vaccine efficacy was 
significantly associated with immunization acceptance and fear of side effects was significantly 
associated with immunization rejection.  However, they did not consider other HBM variables, 
such as disease likelihood.  They suggested that targeting the patients’ social networks for 
information about these two issues would be much more important than targeting the individual. 
Das and Das (2003) provide an important addition to the discussion of factors impacting 
immunization acceptance.  Many studies discuss the effect of experience, both negative and 
positive with vaccination.  Das and Das add a third kind of experience: no effect.  That is, if there 
were no sign of imminent disease, vaccination would seem to be either ineffective or 
unnecessary.  There might be a belief that the disease would not have affected the individual in 
the first place.  This has long been the dilemma of preventive medicine: How do you show the 
effectiveness of prevention when the result is that nothing happens (maintenance of status quo).   
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Das and Das (2003) point out that most families do not weigh immunization decisions as 
a purely cost/benefit ratio with full knowledge of all the factors to be considered.  Concrete 
observation of relationships between vaccination and disease prevention is very limited in most 
people’s experience.  They point out that the first step is establishing trust in healthcare providers 
though the demonstration of the effectiveness of other healthcare programs.  This trust can then 
be transferred to vaccination programs because people would see that healthcare personnel, the 
people who suggest immunizations, are trustworthy in other situations. 
Similar to Das and Das (2003), Sturm, Mays and Zimet (2005) conceptualize vaccination 
decisions as based on the interaction of government mandates, health beliefs and 
social/environmental information.  They note that interaction with healthcare providers can 
specifically affect health beliefs. Sturm, Mays and Zimet (2005) found that American healthcare 
providers rarely initiate discussion of risk associated with childhood immunizations.  They point 
out that parents often take temporal associations between an immunization and some change in a 
child’s behavior as a causative association.  They suggest that provision of explicit information 
on what they refer to as “attributable risk” (p. 450) (e.g. what side effects can be expected, if any 
occur) to the decision maker will help lay decision makers, such as parents, to base decisions on 
scientific evidence.  This, then, is expected to impact health beliefs.    
Sturm, Mays and Zimet (2005) suggest that the HBM has had poor predictive success by 
itself for at least two reasons.  First, many studies using this model do not measure key concepts 
in the model carefully.  Second, although the model may be predictive in theory, changes in the 
environment affect some of the components, such as the belief that a person is susceptible to the 
disease.  They point out that in the 1950s, parents viewed their children as susceptible to polio, 
but today, many parents do not.  In addition, the authors note that cognitive heuristics affect 
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decision making, such as omission bias in the vaccination of children.  People in general prefer 
to avoid action that might harm someone, especially a child, even if that action has a good 
chance of preventing harm. 
The above literature includes research on immunization decision-making by people 65 
and older and decisions by parents for their children.  A 2003 campaign to immunize healthcare 
providers against smallpox provided an opportunity to examine factors influencing vaccination 
decisions by physicians for themselves.  Only 5% (3/60) of the physicians in a large university 
hospital who were contacted about immunization accepted it (Benin, Dmbry, Shapiro & 
Holmboe, 2004).  Physicians who declined immunization cited a negative cost/benefit ratio.  The 
costs of vaccination included risk of contagion from the vaccinated person to family or patients 
(unique to smallpox vaccination) as well as potential side effects.  Most physicians reported that 
they did not believe it likely that there would be a bioterror attack (the only likely means of 
contracting smallpox) in the US in the next 5 years.  Therefore, they assessed benefit from 
vaccination as low. 
The consensus from the above medical literature appears to be that the HBM captures key 
variables describing immunization decisions.  There is great divergence, however, in 
recommendations about how to influence these decisions.  The most popular recommendation is 
some kind of educational approach, for the individual, family or group level.  
 One of the most sophisticated educational approaches was reported in “Practice Notes” 
(2004).  This Health Maintenance Organization organized a flu immunization campaign 
involving every aspect of the HMO member’s contacts with the agency from mass mailings of 
pamphlets, to inclusion or reminders in the phone message while waiting on “hold”, and 
encouragement at every level of care provider to endorse immunization.  In this example, nearly 
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all potential sources of belief influence were addressed in an effort to increase acceptance of flu 
immunization among the elderly.  There was a reported increase from 45% immunization the 
previous year to 95% the year of this particular campaign.  It would appear that this approach, 
especially if applied to all immunization decisions, might be effective, but quite costly. 
How risk associated with disease and immunization is communicated was the subject of a 
workshop conducted by the Institute of Medicine (Stoto, M.A., Evans, G. & Bostrom, A., 1998).  
They found three concerns about how immunization information is communicated: (1) that the 
process often fails to take into account patient variables such as prior knowledge and beliefs, (2) 
that consent to immunize is not always fully informed but instead is frequently mandated, and (3) 
that uncertainty about risks are not always acknowledged.  Ways in which participants thought 
uncertainty about immunization risk should be acknowledged include discussing risks more 
openly with the public. 
In general, research discussed in this section has been largely based on surveys.  
Interpretations are generally consistent with at least some aspects of the HBM (Rosenstock, 
1974).  How health beliefs can be changed is addressed in numerous ways.    The HBM, while 
intuitive and certainly a good description of key issues in decision-making, does not effectively 
identify specific interventions to produce predictable and reliable outcomes.  The HBM does not 
help us understand how health beliefs are influenced or how information is used to affect health 
beliefs.   
As a test of how the variables in the HBM are viewed by those doing research on 
healthcare decisions, the investigator in the studies reported in this dissertation informally 
surveyed members of the Society for Judgment and Decision Making who also were involved in 
healthcare decision research.  Each member meeting the above criteria was asked how they 
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would weight the HBM variables.  3 out of 29 responded with estimates.  All believed that there 
should be a non-zero weight for each of the four HBM variables, but each had a different 
weighting scheme.  This demonstrates the ambiguity of the HBM in application. 
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CHAPTER 3 -  Risky Decision Making Paradigms and 
Immunization Decision Making 
 
Starting in the 1950s, the field of decision making as a science is fairly new (Connolly, 
Arkes & Hammond, 2003).  Yates (1990) divides decision making research into three categories: 
choice, evaluation, and construction.  Choice decision-making is the selection of one behavior 
from at least two alternatives.  Evaluation is weighting of alternative values.  Construction is 
assembling the best alternative from several potential combinations.  Immunization decisions 
constitute choice decision-making because the decision is to accept or refuse an immunization.  
It is decision making under risk since if one refuses immunization, one risks disease; if one 
accepts immunization, one risks side effects of the immunization itself.  As will be discussed 
later, the problem of immunization decision-making is more complex than this simple trade off. 
Behaviorally, the decision is a two alternative decision. 
From the beginning, investigators in the field of decision-making have looked at 
decisions in terms of rationality.  Gigerenzer and Selten (1999) date early thinking in decision 
making from the ideas of Locke, Pascal and Fermat.  According to Gigerenzaer and Selten, 
Locke asserted that the only rational way to make a decision is to frame the problem in 
probabilistic terms.  Pascal and Fermat applied this to decision-making by using gambling as a 
model.  This approach is now called economic decision theory.   Research in decision-making 
that followed this model used constructed alternatives that were mathematically equivalent, but 
structurally different in various ways.  Thus, early research in decision-making used a 
mathematical model focused on making rational decisions.  Rationality was defined as 
  
17
maximizing the payoff in the long run through calculation of mathematical odds of payoffs and 
using these calculated payoffs as a basis for comparing alternatives in each choice situation.  
Yates (1990) identifies two schools of research in risky decision-making: proscriptive 
and descriptive.  Prescriptive decision-making answers the question: what is the best approach to 
making rational decisions?  The assumption that underlies this approach is that if a rational 
approach is used to making decisions when the outcome is uncertain, the best decision will be 
the most rational.  Descriptive decision-making research seeks to describe how people make 
decisions under different circumstances and how different variables affect decision-making.   
The assumption that underlies this approach is that if we understand the process and the pitfalls, 
we can help people make better decisions by designing training programs and decision aids that 
will help them overcome cognitive limitations interfering with good decision-making.   
Prescriptive decision making models will be discussed first. 
Prospect theory is a popular example of a prescriptive model of decision-making that also 
provides a description of how people make decisions (Yates, 1990).  People are faced with at 
least two or more different prospects between which they must decide.  An examination of each 
of these prospects helps to identify specific outcomes that matter to the decision-maker.  People 
usually first eliminate prospects that clearly don’t result in outcomes of importance.  When the 
prospects are narrowed down to two or three alternatives, each with different merits and 
probabilities associated with those merits, the problem can be reduced to mathematical solutions 
for comparison.  Rational choice, as noted above, is choosing the alternative that maximizes the 
utility of the outcomes. 
Expected value (EV) is a quantification of the essential features of alternatives so that the 
problem can be solved mathematically and the correct decision is made obvious.  Each essential 
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or important feature for each alternative is identified.   Multiplying each feature by its probability 
and then adding all these products together for each alternative provides a quantitative measure 
of the expected value of that alternative.  If this calculation is done for each alternative, a choice 
can be made between prospects by simply comparing expected values for each alternative and 
choosing that with the highest expected value.   
When applying EV to a single gamble, one would gamble only if the amount that one 
could win is positive.  Thus, if one were gambling on the state lottery where the odds of winning 
are extremely small, one could calculate the expected value for the lottery by multiplying the 
payoff by the very small probability of winning.  If this calculation were done, one would 
recognize that the logical decision is to refuse to play, since the expected value of playing is 
negative.   
EV is based on objective values of essential aspects of the problem and is measured in 
objective terms: as money or time. When the expected value of a gamble can be quantified, there 
are two questions that can be asked:  (1) which of two bets is the best gamble or (2) to play or not 
to play a single bet. However, in many situations, the value of a prospect is not so easily 
measured in objective terms.  Utilities capture the subjective component of value.  The term 
expected utility (EU) is used to describe a decision context in which a probability is multiplied 
by an subjective utility.  Money is not does not have a linear value because someone who has a 
million dollars does not value addition of $1.00 in the same way that someone who has $100 
would value an additional $1.00.  EU allows for the subjectivity of those values. 
In some situations, both value and probability are subjective estimates.  In these 
situations, the probability of an event is uncertain, so the individual must estimate how likely an 
event is to occur as well as identify its value in that situation.  An early decision scientist, 
  
19
Edwards (1961), introduced the idea of subjectivly expected utilities (SEU) in which the 
participants estimate probabilities as well as give subjective values.  Edwards recognized that 
probability is not necessarily linear.  Cognitively, people do not necessarily treat probabilities in 
evenly spaced increments, as they would mathematically.  Probabilities on the extremes of the 
scale may be treated differently than probabilities toward the center.  For instance, a 1/1,000 
chance of having something bad happen may not move a person to action, but at some point, the 
probability of having something bad happen will increase enough that action is taken.  Where 
that point occurs is subjective.   
An important point that Edwards (1961) made is that SEU is not an additive model.  He 
cites several investigators whose work has supported a multiplicative model.  This issue will be 
addressed later under Functional Measurement (Anderson, 1981).  Further, Edwards pointed out 
that decision-making in real environments is dynamic, with information available at different 
times along a temporal continuum and sometimes contingent on previous decisions.   
SEU is more useful than EV in situations where a person may not have more than one 
“chance” or replication of the situation and there is no objective estimate of probability available.  
The SEU model of decision-making is still normative in that the underlying assumption is that 
people seek to maximize utility and behave in ways that are consistent with the mathematical 
properties of the problem.   
A large body of literature has been published describing ways in which people often 
violate these assumptions.   Simon (1956) pointed out that learning theory provides a better 
model for decision making than do the economic models on which EV and its related rational, 
normative models are based.   
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Simon’s (1956) model took into account elements of the environment that constrain 
decision-making.  As described in Frieman (2002), payoff is only part of the story.  In general, 
participants’ performance has the effect of distributing effort in such a way that a manageable 
cost and payoff occur across various choices over time.  Thus, the participant sacrifices 
maximization of value in any one choice situation for satisfactory value overall.   Simon (1956) 
called this general behavioral approach to decision-making “satisficing” (p 129).  Satisficing is 
adaptive behavior because it allows for change in the environment.  
Tversky and Kahneman (1974) built on Simon’s concept of human limitations in 
cognitive processing capacity and its effect on decision-making.  Their approach is called 
“Heuristics and Biases”.  The term “heuristics” was coined by Simon to denote adaptive 
strategies used to make effective decisions (Simon & Simon, 1962).  
Tversky and Kahneman (1974) used the same term to denote the rules used by novices to 
reduce cognitive complexity of probability judgments in everyday life.  They focus their research 
on how these judgments result in what they see as “severe and systematic errors”(p. 35). 
Tversky and Kahneman (1974, 1984) have identified a number of biases including 
“availability” and “anchoring/adjustment”.   Experiments in this paradigm are set up so that there 
is a mathematically correct answer using EV or Bayes’ Theorem.  A bias is reported when a 
large number of participants give a consistently wrong answer.  The many studies following their 
paradigm have contributed to understanding errors in judgment.   In some experiments half the 
participants are shown the problem stated as loss and half see it stated as gains (Kahneman, K. & 
Tversky, A., 1984).  The problems are mathematically identical, but the frame of reference for 
one gives a reference point of gains (such as saving lives) and the other gives the reference point 
as losses (such as lives that can be lost).  The resulting difference in the decisions made are 
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called “framing effects”.  Numerous experiments have been published reporting various framing 
effects, many of them, like the Asian Disease problem above, involve medical decision-making. 
Moxey, O’Connell, McGettigan and Henry (2003), note that how information is framed 
affects patient decision-making.   They performed a meta-analysis of studies with decisions as 
either survival (a positive frame of reference) or death (a negative frame of reference) in several 
different medical decision contexts: a surgical decision, a medical decision and an immunization 
decision.  They found that there was no consistent effect of framing for surgical decisions 
although the meta-analysis suggested that patients were generally about 1.5 times as likely to 
choose surgery if surgery was positively framed as saving lives.  When the decision was about 
medical treatment, patients were generally more willing to tolerate more toxic treatment when a 
positive frame of reference was used.  When immunizations were the focus of decision-making, 
there was no significant framing effect.  However, they note that many of the studies used in 
their meta-analysis had design problems including lack of authenticity of the scenarios used. 
Ritov and Baron (1990) demonstrated an important effect, which they named the 
“omission bias”, in which undergraduate college students were asked to make a decision to 
mandate vaccination for children.    This effect is important because it showed that these students 
were averse to risking a child’s life, even when the risk of death for the child was small 
compared to the protective effect of the vaccination.   Ritov and Baron’s (1990) study uses the 
classic framing effect approach, with a between-subjects design where the probabilities of both 
frames of reference are mathematically symmetrical.  Their overall result suggests that 
participants generally prefer inaction when action may result in harm, even if action may also 
result in improved outcomes. 
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 Connolly and Jochen (2003) posed a challenge to the omission bias model.  They show 
that design properties of these studies influence the outcome.  Connolly and Reb (2003) 
conducted a series of experiments that showed that the seemingly irrational “omission bias” 
results from a combination of conceptual problems and the scales used for these studies.  They 
propose “regret” as a better interpretation of motivation for immunization decisions.  
Specifically, they found that risk of disease vs. risk of side effects were the factors that influence 
immunization decisions.  They suggest that participants wanted to make a decision that would 
get the best outcome (one they would not regret).    Participants chose action (immunization) if 
they believed a change in the status quo was likely (disease was likely) and action seemed less 
risky than the potential change.  Further, a study by Wroe, Turner and Salkovskis (2004) using 
expectant parents as participants found that anticipated responsibility and regret together 
explained more than 50% of the variance in decisions about immunization made by parents.   
Exploration of omission bias (Ritov & Baron, 1994) suggested that it may explain most 
of what has been called the “status quo” bias.  That is, people prefer the status quo in situations 
where action may result in harm, but also favored giving up the status quo if retaining it required 
action.  Ritov and Baron (1994) also found that people believe that inaction resulting in harm 
was less culpable than action causing the same harm.   They conclude that there is a bias toward 
inaction.    
However, the study by Wroe, Turner and Salkoviskis (2004) above would suggest that 
giving up the status quo is likely when retaining the status quo would result in regret.  Whether 
the omission bias is the same kind of cognitive bias as described by Tversky and Kahneman 
(1974) could be questioned, because this bias may be more a description of a cut point, or policy 
requiring a higher payoff for action, than for inaction.  Action may even be preferred when the 
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status quo would increase risk.  In research on immunization, these results are important, but 
may only describe part of the picture.   
Gigerenzer et al. (1991) reviewed the role of probability theory in psychology.  They 
point out that the normative model of psychology, discussed above, grew out of psychologists’ 
use of statistical reasoning as a model for psychological processes, just as development of 
computers lead cognitive psychologists to use terms from computer technology to describe 
human mental processing.  Neither the statistical model nor the computer model has been 
particularly helpful in understanding decision-making.  Instead, Gigerenzer’s group cites Simon 
(1956) to propose that context is an important consideration in decision making.   
In this framework, the “correct” answer to a problem depends on variables other the 
mathematical calculation used in the heuristics and biases literature.  Context and experience 
both impact what is a correct answer for any individual or group.  As pointed out by Gigerenzer 
and Selten (1999), Simon emphasized the influence of environment, while Kahneman and 
Tversky emphasize the failure of the human.  In contrast, Gigerenzer’s group takes a more 
adaptive approach.   Their research focuses on heuristics that serve to help humans overcome 
cognitive limitations to make adaptive decisions.  
Instead of seeking to develop normative models for correct decision-making, Gigerenzer 
and Selten (1999) propose a framework of decision-making that they believe is significantly 
different from the normative framework.  Their model is called “Fast and Frugal” heuristics.  
They showed people’s decisions to be at least mathematically equivalent to regression models 
using the same variables, as long as the most important variables are used in the equations.  It is 
perhaps important to note that, while introducing their model as non-normative, the proof offered 
is that the results are mathematically similar to those obtained with a normative model.  Their 
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point of view is that successful human decision-making can be described using simple cognitive 
tools that help decision makers be wise decision-makers in difficult environmental situations.  
Kee, et al. (2003) tested Gigerenzer’s Fast and Frugal model of decision making against 
linear logistic regression in a medical decision making task.  They found the two models to be 
similar in accuracy for the decisions made.  It should be noted, however, that both models were 
descriptive.  The use of environmental cues by the decision maker was the outcome of interest.  
The ability to describe cue use by participants in a study is of limited value in predicting 
behavior, since there are numerous cues that may be used by different participants to arrive at the 
same decision.  A problem with Gigerenzer’s (2003) Fast and Frugal approach is that, in order 
for it to be effective, the decision maker must reliably identify the key elements of the problem.  
This descriptive model does not help us to identify which elements are key to adaptive decisions. 
Gigerenzer’s and Selten’s (1999) concept of bounded rationality echoes Simon’s (1956) 
contention that humans are rational within the bounds of both environmental and cognitive 
limitations.    Simon points out that the term “environment” is relevant to human decision 
making only in so far as specific elements of that environment are important to the decisions to 
be made, which he describes in terms of needs, drives and goals.  Thus, if the need is to protect 
oneself from prevalent disease of devastating impact for which there is no cure and no other 
preventive intervention, as it was with polio in the 1950s, even experimental immunization may 
appear to be a good choice.  On the other hand, if the need is to protect oneself from a rare 
disease, as with polio today, even common immunizations may not seem like a good choice 
because all immunizations have less than 100% efficacy and have some risk of side effects.  This 
is consistent with the HBM discussed in the previous chapter and is adaptive.    
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As can be seen, each model of decision making promises to explain how decisions are 
made.  Some models, such as EV and SEU, suggest methods of improving decision-making.  As 
Huber (2004) points out, much of the research on risky decision-making has used artificial 
parameters not reflective of the common decisions to which they are usually generalized.   
Applied to immunization decisions, a normative approach has three problems.  First, 
although one may obtain some estimate of risk relative to disease and to immunization from 
multiple trials (this is done under supervision of the Federal Drug Administration), for an 
individual, there is only one decision.  For the individual, it makes not sense to talk about 
multiple trails.  Secondly, risk and payoffs for immunization are quite unlike those for gambles 
because there is risk of disease if one refuses immunization, and immunization reduces, but does 
not entirely obviate that risk.  Thirdly, there is risk associated with immunization because 
immunization is an invasive procedure with attending side effects.   Estimating risk of disease 
and risk from immunization involves multiple variables including host immunity, likelihood of 
exposure to the organism, virulence of the organism and type of immunization to name just a few 
potentially important variables.   
Some approaches, such as Heuristics and Biases, suggest pitfalls to avoid (without 
specifying how to avoid them).  Still others, such as the Fast and Frugal approach, suggest that 
decision makers should adopt specific strategies, such as looking for dominating cues, to make 
decision making more efficient without sacrificing accuracy.  Like the HBM, specification of 
how one should decide is of limited value in predicting adaptive behavior in realistic situations, 
such as immunization decisions.   
The economic models of decision making and the heuristics and biases model all seek to 
prescribe correct decision making.  The Fast and Frugal approach is also prescriptive.  The HBM 
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is descriptive and vague in its application.  A fourth approach is the Lens Model approach 
(Hammond, 2000).  This approach is generally applied to social policy decisions rather than to 
medical and healthcare decisions.  One strength of this approach is its insistence on 
representative design.  While many economic models and most if not all of the Heuristics and 
Biases studies use highly artificial stimuli, the Lens Model approach seeks to accurately 
represent the decision context with the goal of making findings generalizable to other similar 
situations.  However, Hammond is less interested in how these representative cues are combined.  
The use of linear regression an essential component of the Lens Model approach, assumes 
additivity of components.  Further, Hammond maintains that factorial design cannot be 
appropriately used with representative design because cues do not exist factorially in nature. 
A fifth decision-making research approach uses the Functional Measurement developed 
by Anderson (1981).  Like Simon (1956), this approach recognizes that human decision-makers 
exist in a complex environment and that humans have limited cognitive resources with which to 
make decisions in that environment.  Like the Fast and Frugal group, these investigators do not 
focus on errors.   Instead, they seek to describe how humans respond to specific aspects of this 
environment using what they call Cognitive Algebra. The research of this group will be 
discussed in the Chapter 5. 
The challenge in designing immunization research that is both generalizable and that can 
predict behavior is to design a study that results in the ability to predict immunization behavior 
given a known set of variables.  To do this, it is important to select ecologically valid cues for 
use in the stimuli while allowing for systematic manipulation of variables.   The initial studies in 
this series were designed to address these cue selection issues.  Careful review of medical 
literature on diseases and immunizations and consultation with practicing healthcare personnel 
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resulted in ecologically valid cue selection for three representative disease/immunization pairs.  
The four variables identified in the HBM were selected for inclusion in the information display 
for each disease.   Stimulus display characteristics were then systematically examined to refine 
the presentation of information.  These characteristics included the following: (1) whether 
information was presented as a risk vs. a benefit or as one risk vs. another risk, (2) whether 
information was presented as probabilities or as frequencies, and (3) whether the disease was 
named or a generic term used for the disease, Chapter 4 describes these initial studies and their 
results. 
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CHAPTER 4 -  Initial Studies 
Using the variables identified in the HBM (HBM) (Rosenstock, 1974), a series of 
experiments were conducted to answer four questions: (1) Does framing of the immunization 
decision as a risk/benefit tradeoff vs as a risk/risk tradeoff affect the pattern of response to the 
variables in immunization decision-making? (2)  Do participants respond differently to risky 
immunization decisions when the statements use probability terminology than when the same 
information is provided as frequency statements? (3) Do participants respond differently to 
immunization scenarios when they are given the actual disease name compared to when the same 
information is provided but the disease is not identified?  (4) Does immunization efficacy 
interact significantly with the other HBM variables?  
 The term “framing” used in asking the first question refers to using exactly the same 
information in two conditions, but stating one condition as a trade-off between risk of disease 
and benefit of immunization (reduced risk of disease) and the other as risk of disease vs risk of 
immunization.  The two conditions are mathematically identical and contain the same 
information.  Only the frame of reference is changed from one to the other.  The issues around 
formulating risk/risk and risk/benefit scenarios for immunization decision-making will be 
discussed. 
As discussed in the previous chapters, there has been research to suggest that the first 
three questions may influence responses in risky decision-making.  However, there has been 
little direct study of them in immunization decision-making.  It is important to understand how 
these framing effects might affect decision making prior to examining more directly how the 
immunization variables themselves are combined to make decisions. 
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Risk/Risk vs Risk/Benefit.   Tversky and Kahneman (1974) demonstrated that framing 
decisions as gain leads to different decisions than does framing them as losses.  The Asian 
Disease Problem, Tversky and Kahneman’s (1984) prototype of the framing effect, used 
unrealistic medical scenarios and a between subjects design.  Subsequent studies, as noted in the 
section on risky decision-making, showed various “biases” using the same general approach.  
Baron and Ritov (Ritov & Baron, 1990, Baron & Ritov, 1994, 2004) reported an “omission bias” 
in response to immunization decisions.  Their design, much like the Asian Disease Problem, only 
gave general numbers of “those saved” and “those who would die from side effects of the 
treatment”.  These numbers were not based on realistic disease variables.  Kuhbergere, Schulte-
Mecklenbeck and Perner (2002) identified the artificiality of the tradeoffs in this paradigm as a 
serious problem with decision-making research.  Not surprisingly, results reported using this 
approach are not universal.    
In a study of physicians, Christensen, Heckerling and Mackesy-Amiti, (1995) showed 
that framing of medical decisions did not reliably influence medical decisions made by doctors.  
They found that experienced physicians were influenced by the framing of the problem as risk 
(mortality rates) vs benefit (survival rate) in only two out of twelve hypothetical medical cases.  
 It is not clear how lay people make immunization decisions in a realistic immunization 
decision framed as a trade off between risk of disease and risk of immunization side effects vs 
decisions framed as trade off between risk of disease and benefit of immunization.  Although the 
two conditions can be constructed so that they are mathematically identical and provide the same 
information, examining how one would state the variables to construct the risk/risk frame vs. the 
risk/benefit frame suggests problems with studying framing effects using realistic immunization 
scenarios. 
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The first issue encountered in this study was how to describe immunization decisions as 
risk/benefit trade offs.  This issue arises from the fact that three of the four variables identified in 
the HBM, likelihood of disease, severity of disease, and severity of treatment side effects, are 
logically discussed in terms of risk.  Immunization efficacy is the only variable that can be easily 
stated as a benefit.  For instance, likelihood of disease would be commonly thought of as risk of 
disease without immunization.  This is actually the disease base rate.   
Severity of disease is also a risk issue because it is thought of as risk of severe disease.  
Although the likelihood of some diseases is relatively high, the likelihood of severe disease in 
some of those cases is relatively low.  Conversely, base rate for some diseases, such as Tetanus, 
is low relative to the severity of the disease if contracted.  Further, likelihood of severe disease is 
contingent on contracting the disease.  This is called a conditional probability.  This issue will be 
discussed further in the discussion section. 
In terms of immunization variables, it is possible to state immunization as a benefit by 
stating how likely the recipient of an immunization would be to avoid infection.  In actuality, no 
immunization is 100% effective in all cases.  There is a rather narrow range of immunization 
efficacies, due at least in part to Federal Drug Administration oversight.  In general, the most 
effective immunization is 99% effective (e.g. Tetanus) and the least effective is not less than 
80% effective (Influenza).  Efficacy of most immunizations is in the range of 95% (Smallpox) 
and 90% (Pertussis) (Atkinson, Hamborsky, McIntyre & Wolfe, 2006).   
In addition to prevention of disease, immunization sometimes will lessen the severity of 
disease.  This is the case for influenza immunization (Humes, 2000).  Therefore, immunization 
may be stated as a benefit.   For experimental purposes, the statement of benefit must be stated 
more concretely than is the actual case.   Instead of stating the likely reduction in severity of 
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disease, it is better to state that the disease likelihood is reduced.  To include other variables is 
likely to unnecessarily complicate the picture by adding another variable.  When complexity of 
the stimuli is increased, results can become difficult to interpret.  
Immunization is a two edged sword.  There is no way to describe immunization side 
effects as a benefit.   While side effects of some medications, such as aspirin, might be beneficial 
(prevention of stroke and heart attack), the only circumstances under which immunization side 
effects might be beneficial is in evoking a general immune response.  Even this possibility is not 
usually the point of immunization and is not a general practice.  Therefore, immunization is 
usually thought of as risking loss or negative change from the status quo. 
Side effects of immunizations vary from one kind of immunization to another.  There are 
several types of immunization (Appendix A).  The type of immunization affects not only 
immunization effectiveness ranges, but also what kind of side effects to expect.  For instance, 
purified proteins evoke immunity with little side effect risk while attenuated viruses are much 
riskier.  As in severity of the illness itself, side effect severity is variable from one immunization 
to another and from one individual to another depending on immunization type and host factors.  
However, to design an experiment that uses relatively realistic immunization variables, a 
concrete level of risk of side effect must be stated.   
Experiment #1:  Despite the difficulties of designing a study to test framing effects for 
immunization decisions, it was possible to develop scenarios to experimentally examine 
immunization decision making. The information used to devise these disease probability 
scenarios was obtained from the medical literature (Beers & Berkow, 1999; Chin, 2000; 
Department of Health and Human Services Centers for Disease control website, www.cdc.gov; 
Humes , 2000; Isada, Kasten, Goldman, Gray, & Aberg ,1999, Seattle and King County Public 
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Health Department website, www.metrokc.gov; Mandell, Bennet, & Dolin, 2000; and 
Springhouse Professional Guide to Disease, 1998).  An occupational health physician, who was 
obtaining a MPH at the time, reviewed and approved the pilot scenarios for authenticity (Dr. J. 
Schlageck, personal communication, Spring, 2005).  An infectious disease specialist reviewed 
and approved later versions (Dr. P. Dasaraju, personal communication, Nov 14, 2005).   
The disease variable was stated as risk in all situations, e.g. “Your risk of a disease is less 
than 0.35”.  Immunization was stated risk of shot reaction along with a reduction in disease risk 
in the risk/benefit frame of reference, “e.g. If you get a shot, there is a 0.10 risk that you will 
have a moderate shot reaction, but the  risk of getting a mild case of the disease would be 
reduced to  0.06”.  In the risk/risk frame of reference, immunization side effects were stated just 
as risk (e.g. If you get a shot, there is a 0.10 risk that you will have a moderate shot reaction.  
The risk of a mild case of the disease would be 0.06).  This left participants to calculate the 
reduction in disease likelihood resulting from immunization for themselves.  Immunization side 
effects were always stated as risk (see examples above).   
Each stimulus stated one benefit and two risks.  The three levels of disease severity 
included disease base rates, probability of severe disease, and probability of death from disease.  
The latter two levels of disease severity were actually probabilities conditionalized on getting the 
disease in the first place, but this was not made salient to the participant.  Disease base rate and 
severity information obtained from the medical literature was not stated in conditional 
probabilities and information provided by medical personal is not usually stated in conditional 
probabilities.  Therefore, it seemed realistic to provide information in a factual manner, but not to 
remind the participant that one must first be vulnerable to the disease before becoming part of a 
severity sub group.   
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The three levels of side effect severity were mild, moderate and severe, each with the 
probability of occurrence found in the literature.  There was no description of what the terms 
“mild”, “moderate” or “severe”. Immunization efficacy was held constant across each level of 
immunization side effect for a given disease because shot efficacy for any immunization does not 
change. 
In the interest of developing a representative design, three diseases were selected to 
represent a spectrum of diseases against which one might be immunized.  The base rate of each 
disease is different as is the likelihood of severe disease, if the disease is contracted.   
Immunization effectiveness and side effect likelihood are different for the immunization against 
each of these diseases.  Thus, the probability of disease and severe disease as well as the 
probability of side effects were different for each disease.   
Three diseases for which there are immunizations were selected to provide a variation in 
disease base rate, disease severity, immunization efficacy and immunization side effect profiles.  
The three diseases represented (1) a rare, but severe disease for which immunization is common 
(Tetanus); 2) a common, but less severe disease for which immunization is also common 
(Influenza); and (3) a rare, severe disease for which immunization is not common (Smallpox).  
The immunizations for these diseases ranged in effectiveness from 80% effective (Influenza) to 
nearly 100% effective (Tetanus).  Disease base rates, side effect rates and severe disease rates 
varied from one disease/immunization combination to another.  Immunization efficacy was the 
same across all levels of side effects and was not a variable of interest for the first studies.   
Stimuli: The above analysis of the problem of stating the variables as risk/risk vs stating 
them as risk/benefit resulted in a 3 (disease) by 3 (disease severity with likelihood) by 3 
(immunization side effect severity with likelihood) design.  These variables were printed on 4 x 7 
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card stock with the variables displayed as shown in Figure 4.1.  The difference between the 
risk/risk and risk/benefit wording was insertion of the term “reduced to” probability of disease 
for the risk/benefit format.  A simple statement of probability constituted the risk/risk format.   
It was believed that stating the decision as a risk/benefit trade off would increase 
likelihood of immunization acceptance (Desaraju, personal communication, 14 November, 
2005).  The stimuli were shown with disease severity probability, then side effect probability 
followed by disease benefit (disease probability given shot: D|S) since it was thought that disease 
severity and side effect severity might be the key variables in decision-making.   
Figure 4.1 Stimuli used for risk/benefit vs risk/risk trade off in immunization decisions. 
 
Risk/Benefit 
  Your risk of a severe disease from which you could  
   recover is 0.68. 
 
               If you get a shot, there is a 0.99 risk that you will have a  
               mild shot reaction,  
               but the risk of the disease is reduced to 0.05. 
     
 
Risk/Risk 
                   Your risk of a severe disease from which you could  
                    recover is 0.68. 
 
  If you get a shot, there is a 0.99 risk that you will have a  
  mild shot reaction. 
  The risk of the disease would be 0.05. 
 
 
Participants: Eighteen undergraduate university students taking an introductory 
psychology class agreed to participate for class credit.  Participants were first given a description 
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of the study and signed the informed consent.  They were given 1 hour of class credit for 
participation.  Each study was completed on one set of participants, who participated as a group.  
Stimulus cards, showing the risk of disease x risk of shot reaction x risk of disease with shot 
were shuffled prior to each experiment to randomize stimulus presentation.  Each stimulus card 
included a code denoting which immunization scenario was on the card.  Participants were 
provided with a response form with a separate Likert scale for each stimulus card.  There was a 
blank for the participant to write the stimulus card code adjacent to each Likert scale.  This 
allowed the stimulus to be paired with the response. 
Response Scale: Each scale was anchored with 0 = “Never get a shot under these 
circumstances” to 10 = “Always get a shot under these circumstances”.  A space was provided 
with each response scale for the participant to write in the code for the stimulus card to which 
they were responding.  Participants were instructed to read the one card at a time and answer the 
question: how likely would you be to accept an immunization under the circumstances described 
on the card?  Each participant answered the question for each stimulus card by circling a number 
(0-10) on the response scale and passing the stimulus card to the next person.  They were 
debriefed after participating in the experiment and asked to discuss their strategies for making 
decisions for the immunization scenarios. 
Results: There was an effect of format (F (1, 17) = 8.166, p < .01, η2 = .324) for this 
study.  Stating the decision as risk/benefit did significantly increase likelihood of immunization 
acceptance. 
Experiment #2: Because the goal was to test the effect of presenting the decision as a 
risk/benefit trade off vs. a risk/risk trade off, it was decided that a better method would be to 
present the benefit of disease reduction immediately after disease severity information.  
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Therefore, the experiment was repeated with new participants (N = 14) using the same wording 
as before, but with information on disease reduction with immunization (denoted here as D|S for 
“disease given shot”) presented second (Figure 4.2).   Format was not significant using this order 
of information presentation even though the statements of risk and benefits were the same as for 
the first experiment (F (1, 13) = 1.202, p < .293, η2 = .085).  As can be seen, the effect size was 
also smaller. 
Figure 4.2 Reordering of Stimuli so that side effects are last and reduction in disease is 
second. 
 
Risk/Benefit 
 
   If you don’t get a shot, your risk of a disease  
   from which you could recover is 0.68. 
 
    If you get a shot, your risk of the disease would be   
                reduced to nearly 0.05, 
    But there would be a 0.99 risk of a mild shot reaction. 
       
 
     Risk/Risk 
 
      If you don’t get a shot, your risk of a disease  
      from which you could recover is 0.68. 
              
                  If you get a shot, your risk of the disease would be nearly  
      0.05. 
      The risk of a mild shot reaction is 0.99. 
 
 
Experiment #2R: The difference in results in experiments #1 and #2 were surprising.  
Therefore, experiment #2 was exactly replicated with a new group of students (N=11).  
However, the results were similar for both experiment #2 and its replication, experiment #2R (F 
(1, 10) = 4.041, p < .072, η2 = .288), although the effect size was larger for the replication and 
there was near the .05 level of significance for format.  Because there was no difference between 
the results for experiment #2 and its replication, the data from these two small experiments were 
combined to increase power.   
Since the results of experiment #2 and its replication were similar, the data from these 
two experiments were combined and compared with Experiment#1.  The effect for the variable 
of format is illustrated in Figure 4.3.  There is a significant difference between stating 
immunization side effects right after disease severity (Experiment #1) and stating immunization 
side effects last (Experiment #2).  When immunization side effects are stated last, the reduction 
in disease likelihood is stated right after stating the probability of a given level of disease 
severity.   
Figure 4.3 Comparison of Framing Effects for different orders of information presentation 
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There is no main effect of format (risk/benefit vs. risk/risk) when disease severity and 
reduction in disease likelihood are paired as in Experiment #2.  However, there is a significant 
three way interaction between format, disease type and disease severity (Figure 4.4).  Although 
the response to disease base rates for Smallpox and Tetanus is about the same in both formats, 
there is a small increase in the response to base rates for Influenza with the risk/benefit format.   
Figure 4.4 Interaction of Format with Disease Type and Severity of Disease 
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At the most severe (death from disease) level of disease severity, there is an slight 
decrease in likelihood of immunization for Influenza in the risk/benefit condition and a slight 
increase for Tetanus, while the likelihood for Smallpox remains nearly the same as in the 
risk/risk condition.  Overall, format seems not to affect Smallpox, but does affect immunization 
likelihood for both Tetanus and Influenza to a small degree, especially at the most severe level of 
disease severity.  When the other variables in the experiment were examined, the pattern of 
response was virtually the same for each of the experiments.  These results are consistent with 
studies by Christensen, et al. (1995) and by Moxey, et al. (2003).   
The question addressed here was not whether there was a significant difference between 
the two formats, but rather, which format best presents information to the participant.   
As noted in the discussion above, there are two risk factors (risk of disease and risk of 
side effects from immunization) in these scenarios and only one benefit (reduction in disease if 
immunized).  Placing both risk statements one right after the other may have had the effect of 
enhancing their salience, requiring an explicit statement of “reduction in risk of disease” to offset 
the salience of juxtaposing the two risk statements.  This possibility has relevance for risk 
communication and should be further explored.  However, the goal of the current research is to  
examine the effect of the variables themselves on decision making, so these issues will not be 
pursued at this time.  All further experiments used the format probability of disease (severity) 
followed by probability of reduction in disease given immunization, then probability of 
immunization side effects, the format used in experiment #2 (Figure 4.2). 
Experiment #3: Probability vs Frequency.  Gigerenzer, Hoffrage and Kleinboting (1991) 
point out that people can make accurate judgments when the stimuli are expressed in 
understandable terms.  For people without sophisticated mathematical and statistical training, it 
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may be that likelihood estimates presented in terms of frequency of events will be better 
understood than the same information presented as point probabilities of events.  This was tested 
in an experiment using stimuli identical to that discussed above except that frequency was given 
instead of probability of events, as had been done in the previous studies.  Figure 4.5 shows the 
stimuli for Experiment #3, which uses frequency statements to describe likelihood of events 
rather than probability statements. 
Figure 4.5 Stimuli for Experiment #3 using frequency statements instead of probability 
statements 
 
Risk/Benefit 
 
   If you don’t get a shot, your risk of a disease  
   from which you could recover is 680/1,000. 
 
    If you get a shot, your risk of the disease would be   
                reduced to nearly 50/1,000, 
    But there would be a 990/1,000 risk of a mild shot reaction. 
       
 
Risk/Risk 
 
      If you don’t get a shot, your risk of a disease  
      from which you could recover is 680/1,000. 
              
      If you get a shot, your risk of the disease would be nearly  
      50/1,000. 
      The risk of a mild shot reaction is 990/1,000. 
 
 
Results of this study were combined with those of Experiment #2 to test the effect of 
stating likelihood information as probabilities (Exp#2) or as frequencies (Exp#3).  Figure 4.6  
 
Figure 4.6 Information provided as probability statements or as frequency statements  
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shows this comparison.  There is no main effect of stating information as likelihood or 
probabilities and no interaction with other variables. 
Response to the key variables of the HBM was significant, both when information was 
provided as probability statements and as frequency statements (Table 4.1). The only exception 
was a null main effect for disease severity when information was presented as frequency.   
Interestingly, frame (risk/risk vs. risk/benefit) was non significant when frequencies were 
used instead of probabilities.  Effect sizes were a little larger when information was presented as 
frequency statements.  While there was a significant three way interaction of Disease type x Side 
effect x Frame (format) for the stimuli when information was presented as probability statements 
there was no significant interaction between these variables when information was presented as 
frequencies.  When information was presented as frequencies, there was a significant three way 
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interaction between disease type x severity of disease x Frame (format) and none for information 
presented as probabilities. 
Table 4.1 Results of studies to examine effect of probability statements vs frequency 
statements 
 
Variable Probabilities  
(Experiment #2)        
(N = 25) 
Frequencies  
(Experiment #3) 
            (N = 21) 
ME Disease Type F (2,48) = 38.537, p 
<.001, η2 = .616 
F (2,40) = 57.655, p < 
.001, η2 = .742 
ME Severity SE F (2,48) = 18.752, p 
<.001, η2 = .439 
F (2,40) = 21.838, p < 
.001, η2 = .522 
ME Severity Disease F (2,48) = 9.706, 
p < .05, η2 = .288 
 
     ns 
ME Frame of Ref. F (1,24) = 4.899, 
p < .05, η2 = .17 
 
     ns 
Disease Type x SE F (4,96) = 6.706, 
p <.05, η2 = .218 
F (4,80) = 6.120, 
p < .001, η2 = .234 
Disease Type x Severity 
of Disease 
F (4,96) = 33.337, p 
<.001, η2 = .581 
F (4,80) = 32.976, p < 
.001, η2 = .662 
Severity of Disease x 
Severity SE 
 
      ns 
 
      ns 
Disease Type x Frame       ns       ns 
SE x Frame       ns       ns 
Disease Severity x Frame       ns       ns 
Disease Type x SE x 
Severity of Disease 
 
      ns 
 
      ns 
Disease Type x SE x 
Frame 
F (4,96) = 6.649, p <.05, 
η2 = .098 
 
      ns 
Disease Type x Severity 
of Disease x Frame 
 
      ns 
F (4,80) = 3.835,  
p < .01, η2 = .161 
SE x Severity of Disease 
x Frame 
 
      ns 
 
     ns 
Four way interaction       ns      ns 
 
   Experiment #4: Naming Disease vs. No Name for Disease.  The third issue of concern 
is the effect of knowing the name of the disease for which the likelihood information is provided.  
That is: Does knowing the name of the disease affect how one responds to the likelihood 
information about the disease/immunization variables?  To answer this question, stimuli identical 
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to that shown participants for examining the effect of frequencies on decision patterns were 
shown to a new group of participants (N = 18), but actual names of the diseases for each example 
were included in the stimuli.  Figure 4.7 shows an example of the stimuli used for Experiment#4. 
Results of comparing using correct disease names with using a more generic term “a 
disease” are shown in Figure 4. 8. There is no significant effect of using the real disease name on 
likelihood of immunization.  There is, however, a significant interaction with Disease Type as 
can be seen in Figure 4.9.  When the correct disease name is used, there is a slight increase in 
likelihood of immunization for both Smallpox and Influenza and a slight decrease for Tetanus. 
 
Figure 4.7 Stimuli for Experiment #4 using correct disease names 
 
Risk/Benefit 
 
   If you don’t get a shot, your risk of smallpox  
   from which you could recover is 680/1,000. 
 
    If you get a shot, your risk of smallpox would be   
                reduced to nearly 50/1,000, 
    But there would be a 990/1,000 risk of a mild shot reaction. 
       
 
Risk/Risk 
 
      If you don’t get a shot, your risk of smallpox  
      from which you could recover is 680/1,000. 
              
       If you get a shot, your risk of smallpox would be nearly  
      50/1,000. 
      The risk of a mild shot reaction is 990/1,000. 
 
 
Figure 4.8  Comparison of Naming the disease or not.   
Standard Error for “no name” conditions is .325 and for “name” condition is .351. 
Experiment #4 Comparison of Using No Disease 
Name vs. Correct Disease Name
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The pattern of results was similar to that seen with all the other experiments (Table 4.3).  
Although there are consistent main effects for disease type and side effects, there is also a 
consistently significant interaction between disease type and side effect severity as well as 
between disease type and disease severity.  There is a three way interaction between Disease type 
x Side Effects x Frame for Experiment #4, although this was not the case for Experiment #3.  
The significant interaction between Disease type x disease Severity x Frame seen in Experiment 
#3 was not found in Experiment #4.  Therefore, these interactions seem uninteresting.  However, 
the persistent two-way interactions involving Disease Type raised the issue of the possibility that 
there was something about the disease profile that might be affecting this interaction.  One 
obvious source of difference between was that, for each disease, immunization efficacy was 
constant across all levels of side effect.  
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Figure 4.9 Interaction of naming disease with disease type 
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Standard errors for disease type in each name condition are presented in Table 4.2 below. 
Table 4.2 Standard Errors for disease type in each name condition. 
 
  Standard Error 
No Name   
 Tetanus .343 
 Influenza .377 
 Smallpox .321 
Name Used   
 Tetanus .370 
 Influenza .407 
 Smallpox .347 
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Table 4.3 Results of studies to examine effect of no name vs. correct name of disease 
 
Variable No Name 
(Experiment #3) 
(N = 21) 
Correct Disease Name 
(Experiment #4) 
(N = 18) 
ME Disease Type F (2,40) = 57.655,  
p < .001, η2 = .742 
F (2,34) = 38.097, 
 p < .001, η2 = .691 
ME Severity SE F (2,40) = 21.838,  
p < .001, η2 = .522 
F (2,34) = 11.864,  
p < .001, η2 = .411 
ME Severity Disease  
      ns 
F (2,34) = 5.227,  
p < .05, η2 = .235 
ME Frame of Ref.  
      ns 
 
      ns 
Disease Type x SE F (4,80) = 6.120,  
p < .001, η2 = .234 
F (4,68) = 7.631,  
p < .001, η2 = .310 
Disease Type x Severity 
of Disease 
F (4,80) = 32.976,  
p < .001, η2 = .662 
F (4,68) = 32.901,  
p < .001, η2 = .659 
Severity of Disease x 
Severity SE 
 
      ns 
 
      ns 
Disease Type x Frame  
      ns 
F (2,34) = 3.387, 
 p < .05, η2 = .166 
SE x Frame       ns       ns 
Disease Severity x Frame       ns       ns 
Disease Type x SE x 
Severity of Disease 
 
      ns 
 
      ns 
Disease Type x SE x 
Frame 
 
      ns 
F (4,68) = 2.529,  
p < .05, η2 = .130 
Disease Type x Severity 
of Disease x Frame 
F (4,80) = 3.835,  
p < .01, η2 = .161 
 
      ns 
SE x Severity of Disease 
x Frame 
 
      ns 
 
      ns 
Four way interaction       ns       ns 
 
Experiment #5: A fifth experiment (N = 14) was conducted in which shot effectiveness 
was systematically varied across the other two variables.  The format for this experiment was the 
same as for the previous experiment, except shot effectiveness was varied with each disease 
profile (severity of disease by severity of shot side effect) and instead of a generic disease name 
or a real disease name, a hypothetical disease name was used for each disease.  In this way, 
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immunization efficacy could be varied without calling attention to the fact that the disease was 
the same with different shot efficacies.   Also, the immunization effectiveness for influenza was  
Figure 4.10 Stimuli for Experiment #5 using artificial disease names and systematically 
varying immunization efficacy  
The card code shown in the upper left corner of each stimulus denotes the disease type (Neches 
River Disease (smallpox), level 1 of disease severity by level 1 of immunization side effects 
using immunization efficacy for Tetanus (NR 11 PT), Influenza (NR 11 PIf) or Smallpox (NR 11 
PS). 
NR11 PT 
   If you don’t get a shot, your risk of Neches River    
   Disease  
   from which you could recover is 680/1,000. 
 
    If you get a shot, your risk of Neches River Disease would be  
                reduced to nearly 0/1,000, 
    But there would be a 990/1,000 risk of a mild shot reaction. 
       
 
NR11 PIf 
If you don’t get a shot, your risk of Neches River Disease  
from which you could recover is 680/1,000. 
 
If you get a shot, your risk of Neches River Disease would be   
            reduced to nearly 100/1,000, 
But there would be a 990/1,000 risk of a mild shot reaction. 
       
 
NR11 PS 
   If you don’t get a shot, your risk of Neches River Disease  
    is 990/1,000.  
 
    If you get a shot, your risk of Neches River Disease would be  
                reduced to nearly 50/1,000, 
    But there would be a 990/1,000 risk of a mild shot reaction. 
       
 
increased to 90% from the previously used 80%.  In the medical literature, effectiveness for this 
immunization is rated as ranging from 70%-90%.  By increasing the efficacy shown participants, 
shot efficacy could be rank ordered in terms of effectiveness.   Figure 4.10 shows and example of 
stimuli used for experiment #5. 
Results of this experiment were consistent with that of the previous experiments with two 
notable exceptions. First, there was a significant main effect of shot efficacy (F (2, 26) = 20.897, 
p < .001, η2 = .616).  Second, there was no main effect of immunization side effects in this 
experiment.  When shot efficacy was held constant within stimuli for each disease in all previous 
experiments, there was a significant main effect of immunization side effects with an effect size 
between .325 and .660.  The significant two-way interactions seen in all previous experiments, 
Disease type with Side Effect Severity (F (4, 52) = 7.789, p < .001, η2 = .375) and Disease Type 
with Disease Severity (F (4,52) = 40.416, p < .001, η2 = .757) were also seen in this experiment 
(Figures 4.11 and 4.12).  However, when immunization efficacy was systematically manipulated,  
Figure 4.11 Two-way interaction of Disease type and Side Effect Severity 
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Figure 4.12 Two-way interaction of Disease Type and Disease Severity 
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Note that likelihood displayed in these graphs are transformed by a factor of 10.  Transforming the scale from 0-10 
to 0-100 makes the graphs easier to interpret. 
Figure 4.13 Two-way interaction of Disease Type with Immunization Efficacy. 
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Legend: D|S = Disease given Shot.  This is immunization effectiveness (see p. 35) 
Note that likelihoods displayed in this graph are transformed by a factor of 10. 
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there was also a significant interaction between disease type and immunization efficacy (F (4, 
52) = 4.606, p < .01, η2 = .262).    This interaction is shown in Figure 4.13.   
The interaction of disease type and immunization side effect severity, although 
significant, does not appear to be impressive.  The interaction of disease type and disease 
severity is compatible with probabilities associated with each level of each disease regardless of 
whether participants are presented the disease base rate or the disease severity level.  
However, in the interaction between disease type and side effect severity, only the most 
severe level of immunization side effect was involved in the interaction.  In the case of the 
interaction between disease type and disease severity, participants were clearly responding to the 
probability information provided in the stimuli.  Tetanus has a very low disease base rate, but 
very high mortality.  The response to this information is clear from the graph, which shows low 
likelihood of immunization given low base rates and high rate of immunization given high 
mortality.  Likewise, Smallpox has a very high disease base rate (given exposure), but a 
moderate (30% mortality).  This information is reflected in participants’ preference for 
immunization against this disease both in the base rate and the mortality conditions.  Influenza 
has a lower disease base rate than does smallpox, but a higher base rate than does Tetanus.  
However, Influenza has a low mortality rate compared to either of the other two diseases.  These 
facts are reflected in participants’ estimates of immunization likelihood.  It appears that shot 
efficacy interacts primarily with disease factors, since there is no significant interaction between 
shot efficacy and either severity of immunization side effect or shot efficacy and disease 
severity. 
The above series of experiments help to clarify the variables from the HBM that impact 
decisions about immunization.  More importantly, they show that those variables interact.  The 
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fact that there is a consistent main effect of disease type with a large effect size and a consistent 
interaction of this variable with the other variables across all experiments suggests that disease 
base rate may be key to immunization decision-making.   Initial studies examined formatting 
issues for stimuli and show that interaction of specific variables is important to predicting 
immunization decision-making.  The fifth study showed the importance of the interaction 
between disease and immunization efficacy. 
Examination of format (risk/risk vs. risk/benefit, probability vs. frequency, and name 
versus no name) suggests that these issues are not as important as they might appear on the 
surface.  Therefore, one could safely present information to participants in any of these formats 
and expect to get results described above.  However, the nature of the interaction between 
disease base rates and immunization efficacy appear to be key to understanding how decisions 
about immunization acceptance are made.  When there is an interaction between variables, it is 
important to ask the question: How are the two variables combined?  Functional Measurement 
(Anderson, 1981) offers a method of answering this question.  Understanding the nature of the 
interaction between disease and immunization effectiveness should help us to understand 
immunization behavior when changes occur in the variables and thus enable us to generalize 
across diseases and immunization contexts. 
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CHAPTER 5 -   Functional Measurement Applied to Immunization 
Decision Making 
Information Integration Theory (ITT) (Anderson, 1981) examines how people combine 
information from their environment to arrive at a judgment.  One advantage of IIT is its ability to 
predict future behavior based on how cues are combined (generally additively or 
multiplicatively).  Although IIT is based on mathematical models of how cues are combined, it is 
not a normative model because there is no “correct” answer, but rather a description of how 
different cues are incorporated to provide an overall behavioral outcome.  It is important to 
understand that the mathematical description of cognitively driven behavior provided by ITT 
does not imply that people actually perform the mental calculations, but rather that these are “as 
if” models.   
An example of the difference between description of the process and concrete translation 
of that process is provided from perception research.  For the purposes of studying 
proprioception, one can calculate the amount of pressure placed on a glass by fingers, where the 
fingers are placed and how many it takes to provide enough support to pick up a given glass.  
However, no one would assume that the person who picks up the glass is actually performing 
those calculations nor is his/her ability to pick up a glass dependent on their ability to perform 
those calculations.  In the same way, when making decisions, people select and cognitively 
combine cues to arrive at a decision.  ITT is a method of describing mathematically how those 
cues are used.  Using that knowledge, clinicians can predict how people are likely to respond to 
changes in cue values, such as increase in disease likelihood, etc. 
As Weiss (2006) succinctly states, although people often believe they are using a 
complex process to make a decision, analysis of that process may reveal much simpler rules of 
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cue combination.  This is one reason that surveys asking for insight into decision processes, such 
as how one decides to get an immunization or not, is of limited utility and must be followed up 
by careful experimental testing of how the individual actually uses those cues to arrive at a 
decision.   
Although stating that complex processes often can be boiled down to simple decision 
rules echoes the Gigerenzer and Selton (1999) approach of Fast and Frugal Heuristics, IIT goes 
beyond identification of the cues and describes how they are integrated cognitively.  The F&F 
approach would identify which cues are most diagnostic.  ITT would both identify them and 
describe how they are combined and weighted to arrive at a decision.  Functional measurement 
provides a statistical picture of how objective information is subjectively combined to inform 
behavior (Anderson, 1981). Anderson called this integration function “cognitive algebra”.  A 
significant linear by linear effect suggests that participants are using an additive model of 
information integration.   The presences of other effects suggest other models, including 
multiplicatively.  This ability to describe algebraic combination rules provides predictive power.   
The predictive power of ITT can be seen in an example of immunization decision 
making, using simulated data.  As was seen in the discussion of the HBM of healthcare decision 
making in Chapter 2, two variables reported in survey research to be associated with healthcare 
decisions are whether or not a disease is likely to affect the individual and the effectiveness of 
the offered treatment.   Using this logic, you would expect that a person who thought there was 
some chance that they could be contract a communicable disease and who thought that an 
immunization was likely to improve their odds of surviving the accident, would be more likely to 
get immunized than one who held neither of these beliefs.  
Example of application of ITT to healthcare decision problem: The ITT approach to 
prediction can be used in a hypothetical immunization example.  To study such an decision, the 
degree of belief that one might get a disease and the degree of belief that an immunization is 
likely to improve odds of surviving that disease would need to be varied to present multiple 
combinations of these two variables.  Responses would be an estimate of the participant’s 
likelihood of accepting and immunization under each combination of the two variables.  Further, 
IIT focuses on the interaction (integration) of the two variables rather than on either variable in 
isolation.  If there is no interaction, the variables are operating independently and there is no 
integration.  The tool used in ITT is Functional Measurement.  Functional Measurement 
measures the function of stimuli in evoking a response. 
Figure 5.1 illustrates a hypothetical main effect of likelihood of disease on likelihood of 
immunization.  Here, there is a systematic step increase in likelihood estimates of immunization 
Figure 5.1 Main effect of belief that a disease is likely 
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as the independent variable of likelihood of disease.  There would likely be a main effect as well 
of belief that immunizations prevent disease.  Figure 5.2 illustrates a main effect of belief that 
immunizations are effective in preventing disease, using simulated data. 
Figure 5.2 Main effect of belief that immunization prevents disease 
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Neither of these beliefs is likely to exist in isolation however, so one would want to know 
how they interact.  Figure 5.3 illustrates the interaction of simulated data from the two HBM 
variables for immunization effectiveness if people combine the two isolated variables additively.  
The diagnostic evidence for additivity is the absence of a significant interaction.  This is seen on 
the graph in parallel lines as levels of each variable change.  As can be seen, although likelihood 
of immunization falls off with declining belief that immunizations are effective, it falls off at the 
same rate for every level of belief in likelihood one could get a disease.  With this information, 
one could increase likelihood of immunization by focusing on lives saved with immunization vs 
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lives lost when people are not immunized and expect that there would be the same amount of 
increase in immunization for everyone, regardless of how likely they would be to get a disease. 
Figure 5.3 Additive model of integration of disease base rates with immunization 
effectiveness. 
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However, if participants’ combination of the likelihood of getting a disease with the 
effectiveness of immunization is multiplicative, a different prediction would be made.  Figure 5.4 
illustrates simulated data, but with a multiplicative interaction.  When people multiplicatively 
combine belief that they might get a disease with belief that immunizations work, the degree of 
belief in both variables matters very much.   When a multiplicative rule is used to combine 
information, the impact of a change in the level of one variable will vary with change in the level 
of the other variable so that a fan shape is seen as the two variables diverge from one another.  
The fan shape is diagnostic of multiplicative information integration. 
When the belief that immunizations work is low, there is little difference in likelihood of 
immunization for all levels of belief that one might get a disease.  However, as belief in 
effectiveness of immunization increases, the effect at different levels of disease likelihood is 
magnified.  Therefore, a dual approach is warranted because increasing the belief that 
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 Figure 5.4 Multiplicative model of integration of disease base rates with immunization 
effectiveness. 
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Legend: DB1= disease base rate low, DB2 = disease base rate moderately low, DB3 = disease base rate moderate, 
DB4 = disease base rate moderately high, DB5 = disease base rate high 
Sht1 = shot efficacy low (diamond), Sht2 = shot efficacy moderately low (square), Sht3 = shot efficacy moderate 
(tiragle), Sht4 = shot efficacy moderately high (x), Sht5 = shot efficacy high (*). 
 
immunizations work at the same time one increases the belief in the likelihood that one might get 
a disease has enormous payoff in terms of increasing immunization rates.   
Functional Measurement applied to healthcare problems. Rundall and Weiss (1994, 1998) 
reported how functional measurement predicts behavior in two separate experiments, one with 
healthcare personnel (nurses) and the other with patients.  Rundall and Weiss (1994) used 
Functional Measurement (FM) to examine how nurses’ fear (the dependent variable) resulted 
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from the integration of two independent variables of contagiousness and severity of disease.  A 
factorial arrangement of disease variables based on actual, but un-named, diseases was used for 
the experiment.  By systematically examining how fear was affected by the two disease 
variables, this experiment showed that fear could be predicted to increase multiplicatively with 
increases in transmissibility and severity of disease.  Knowing this, training of nurses to prevent 
contamination should address both variables. 
Rundall and Weiss (1998) used F M again to explore how disease symptom severity (the 
disease severity experienced by the patient) and disease prognosis (how severe the disease could 
become) interacted to influence patients’ compliance with recommended medical treatments.  A 
multiplicative relationship between the two variables predicted medication compliance in this 
study.  When the variables were changed to examine the relationship of medication side effects 
and disease prognosis on medication compliance, this relationship was shown to also be 
multiplicative.   
Knowing both multiplicative interactions, patient education regarding medication should 
teach each of these variables carefully so that patients understood not only medication how 
affects their current experience the disease, but also how it prevents the disease from worsening.  
In terms of the interaction between side effects and disease prognosis, a multiplicative effect 
would suggest that patients be taught to report side effect early so that medications could be 
adjusted.   They then would be more likely to continue with treatment, preventing more severe 
disease. 
Immunization behavior is a preventive medicine issue for which functional measurement 
might be useful.  Initial studies conducted with the four variables identified by the HBM, 
(disease likelihood, disease severity, immunization side effect severity and effectiveness of 
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immunization) explored these variables for three different diseases with different stimulus 
display characteristics.  The largest effect size (consistently around η2 = .60) was for the variable 
of disease base rate, which consistently interacted with the other variables.  
Through all of these studies, a persistent interaction between variables was observed.  As 
noted in chapter 4, significant interactions were found in study five for Disease type by disease 
severity, disease type by side effect severity and for disease type by shot efficacy.  Since the only 
important interaction between immunization side effects and other variables was at the most 
severe level of immunization side effects, further exploration of this interaction is less interesting 
than are other interactions.  The interaction between Disease Type and Disease severity, while 
relevant, seems relatively easy to explain.  Immunization effectiveness appears to interact only 
with disease type, and not with disease severity or with immunization side effects.   
     It appears that disease base rate might be key to understanding the interaction between 
disease type and immunization efficacy.  Exploration of how information on both of these two 
variables may be important to designing immunization programs, establishing public policy on 
immunization and providing informed consent to individuals for immunization.  Functional 
Measurement was therefore used to explore the nature of the interaction between disease base 
rates and immunization efficacy. 
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CHAPTER 6 -  Method for Functional Measurement of Interaction 
between Disease Base Rates and Immunization Efficacy 
 
Two research questions are addressed in this study:  First, how does probability of 
disease (disease base rate, referred to as “D”) and effectiveness of immunization against the 
disease (referred to as probability of disease given shot, or simply “D|S”) combine to influence 
participant’s willingness to accept the immunization?   Secondly, if there is an interaction 
between these two variables, what is the nature of that interaction?  
Stimuli developed here through a series of pilot studies (see chapter 4) use accurate 
probabilities for two variables found to be important to decision making: probability of disease 
and effectiveness of immunization.  The latter is a conditional probability predicating reduction 
in disease on the disease base rate.  Although one might expect that both base rates for disease 
and reduction in the base rate due to immunization might be absolutely known, this is not always 
the case.  Disease base rates are related to a number of variables, as is immunization 
effectiveness.  Therefore, the best estimates available for these variables were obtained from the 
medical literature (Atkinson, et al. 2006). 
As noted in Chapter 3, Hammond (2000) pointed out that providing ecologically valid 
cues to the participant is important to generalizability of the results.  This series of studies has 
attempted to provide ecologically valid cues by using diseases, immunizations and probabilities 
from the medical literature.  However, to provide the participant with all possible cue 
information at one time is to complicate the decision to the point that results may be 
uninterruptible.  Simplifying accurate disease probability information for experimental study 
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appears to provide valuable information about how participants respond to key disease variables 
in an immunization decision-making situation.  In the present study, the nature of the interaction 
between disease base rates and immunization efficacy was the focus of investigation.  It has 
already been established that there is a significant interaction between these two variables. 
Based on findings from earlier studies, the final study used the following elements:  The 
probability of disease without immunization was stated first.  This was followed by the estimated 
effectiveness of immunization for that disease.  That statement was followed by the probability 
of severe side effect for a given immunization; probabilities were stated in frequency of 
occurance/1,000 people.   
In the interest of ecological validity, real diseases and accurate probabilities were used as 
much as possible.  However, some cells in the design required disease base rates and 
immunization effectiveness that were not readily found in diseases against which participants 
might be asked to be immunized.  In these cases, hypothetical diseases were used that fit those 
categories.  These issues are discussed further in the stimulus section.   
However, pilot studies demonstrate that more complex disease scenarios are not 
necessary to study the key factors influencing these decisions.    
A 3 (disease probability without immunization) x 4 (reduction in disease probability with 
immunization) design was used to examine the effect of the immunization variables of disease 
base rates and immunization effectiveness on acceptance of immunization.  The variable of 
immunization side effect was included in the scenarios for authenticity, but was held constant 
and is therefore, not part of the study.  Review of the medical literature reveals that most 
immunizations are reported to have a very low incidence of “severe” side effects.  Since this rate 
is nearly uniformly about 1/1,000 or lower, this figure was used for all scenarios.   The only two 
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variables that were systematically manipulated therefore were the variables of disease base rate 
and immunization effectiveness. 
Participants included 31 traditional undergraduate students (ages 18-21, mean 19) taking 
an introductory psychology class who participated for class credit.  Connolly and Jeb (2003) 
found that the behavior of adults was comparable to that of undergraduates.    However, it may 
be possible that experiences accumulated by non-traditional students would influence their 
likelihood of accepting immunizations.  A solicitation was sent through the Adult Student 
Services department at the university inviting non-traditional students to participate.  29 
nontraditional students accepted this solicitation.  No class credit could be given these 
volunteers; therefore, a discount pizza coupon was offered these students for participation.   
Non-traditional students were both graduate and undergraduate students.  Two non-
traditional participants reported during debriefing that they had not followed the instructions for 
the experiment.  In spite of explicit instructions to look only at one stimulus card at a time and 
not to review previous cards, one non-traditional student reported reviewing previous stimuli in 
order to “make sure responses were consistent”.  The other reported being unable to make 
decisions based on the information provided.  Review of this participant’s data revealed that all 
responses were between 45 and 55 on a 100mm scale.  Data from these two participants was not 
used for analysis.   
One other student provided an estimate of 100 (always accept immunization) for all 
stimuli.  However, this student stated that it was her policy to accept immunization whenever it 
was offered.  Since this stated policy is one extreme of how participants may view decision-
making and was accurately reflected in their responses, this student’s data was included in the 
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data for analysis.  Therefore, data from 27 non-traditional students was used (ages 24-62, mean 
36.44). 
None of the traditional undergraduate students were parents.   Fourteen of the non-
traditional students were parents.  There were a total of 18 males and 40 females who 
participated in the experiment.  Four of the 18 male participants were non-traditional students 
and the remaining 14 male participants were traditional students.  
There was little ethnic diversity.  All but 4 of the non-traditional students were Caucasian 
with the four non-Caucasian students each representing a distinct ethnic group.  Some of the 
Caucasian non-traditional students were non-American, but were Caucasians from Europe.  
Diversity among the traditional students was even less with only three students reporting non-
Caucasian heritage (two Hispanic and one African-American).  Therefore, all non-Caucasian 
students were grouped together.  This still represented a very small group of 7 out of 58 
participants. 
A pilot study had suggested that healthcare training might impact likelihood of 
immunization acceptance.  Participants were divided into three groups based on healthcare 
training:  no training (14 participants), lay training (12 participants), and professional training (5 
participants. 
 Stimuli were presented in the format already discussed with only the changes noted 
below.   Stimuli were printed on 5 x 7 card stock and re-randomized using a list of random 
numbers prior to each administration.  A set of 3 stimuli was presented first each time and the 
same stimuli presented again at the end to examine any effect of learning during the experiment.    
Table 6.1 shows the diseases and immunizations that were used as stimuli in this study.  
Several immunizations that a college student might be asked to accept were selected for 
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construction of the stimuli.  In addition to immunizations now commonly recommended or 
required by most colleges (e.g. against bacterial meningitis and hepatitis B), other immunizations 
that might be recommended were included (e.g. pneumonia).  One immunization, from the initial 
studies, which could be recommended in the event of a bioterror incident, Smallpox, was also 
included.  It seems important to include at least one such disease in any study of immunization 
behavior to enable healthcare personnel can anticipate variables of importance if there were need 
to immunize against such a disease.   Since the name of the disease had no effect in pilot studies, 
correct disease names were used in this study.   
The real immunizations displayed in Table 6.1 are: Bacterial Meningitis, Pneumonia, 
Hepatitis B, Smallpox, Pertussis, and Chickenpox.  Frequencies for Meningitis and Smallpox are 
adjusted a slightly to fit them into the matrix (smallpox may be more contagious than 90% and 
Meningitis may be less contagious than 1%).  At the debriefing, participants were provided with 
the actual incidence of these diseases along with the actual immunization efficacy according to 
Epidemiology and Prevention of Vaccine-Preventable Diseases 9th Ed. (2006). 
As noted earlier, two problems were encountered in designing the experiment:  First, no 
actual diseases were found to fit into the remaining cells of the 3X4 design.  Therefore, 
Hypothetical diseases were inserted into the empty cells and given names that might be 
interpreted as disease names.  Since the use of hypothetical names in the pilots yielded the same 
pattern of results as did real disease names, this seemed to be a reasonable solution.  Potential 
names to be used for these hypothetical diseases were selected after collaboration with healthcare 
personnel with whom the primary investigator works.  
Second, absolute probability information was required to fit diseases into cells in the  
 
Table 6.1 Probability of Disease (Given Exposure) Without Immunization (Base Rate for 
Disease) 
Note that hypothetical disease names are italicized. 
Probability of Disease 
(Given Exposure) With 
Immunization 
(below) 
Disease 
         p = 1/1,000 
Disease 
        p = 50/1,000 
Disease 
      p = 
900/1,000 
 
 
Shot effectiveness = more 
than 999/1,000 are 
protected. 
Bacterial 
Meningitis 
p disease= 1/1,000 
With shot, 
999/1,000 are 
protected 
Verde’s Disease 
p disease = 
50/1,000 
With shot, 
999/1,000 are 
protected 
 Fibularosis 
p disease = 
900/1,000 
With shot, 
999/1,000 are 
protected 
 
 
Shot effectiveness = 
950/1,000 are protected 
Casalosis 
p disease =1/1,000  
 
With shot, 
950/1,000 are 
protected 
Black Spot Fever 
p disease = 
50/1,000 
 
With shot, 
950/1,000 are 
protected 
Smallpox 
p Disease = 
900/1,000 
 
With shot, 
950/1,000 are 
protected 
 
 
Shot effectiveness = 
900/1,000 are protected 
Neches River 
Fever 
p Disease = 1/1,000 
 
With shot, 
900/1,000 are 
protected 
  Hepatitis B 
p disease = 
50/1,000 
 
With shot, 
900/1,000 are 
protected 
      Pertussis 
p Disease = 
900/1,000 
 
With shot, 
900/1,000 are 
protected 
 
 
Shot effectiveness= 
800/1,000 are protected. 
      Pneumonia 
p disease = 1/1,000 
 
With shot, 
800/1,000 are 
protected 
    Appalachian      
Pharyngitis 
p disease =50/1,000 
 
With shot, 
800/1,000 protected
Chickenpox 
p Disease 
=900/1,000 
 
With shot, 
800/1,000 are 
protected 
 
matrix.  Since disease probability is situational, some diseases were given a probability that only 
fits some situations, although there is a range of probabilities that might be associated with that 
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disease, depending on other factors, such as personal behavior or environment.  The actual 
diseases and their actual range of probabilities and shot efficacy were provided to participants as 
part of the debriefing to clarify any misunderstanding. 
 As noted earlier, in nearly every case the incidence of severe immunization reaction is 
nearly 1/1,000 and sometimes less, so the uniform number of 1/1,000 was used to make the 
scenarios seem authentic.  This factor was not varied because previous studies suggested that it is 
not the primary focus of immunization decision making for participants 
 In addition to the experimental scenarios, the following diseases/shot combinations were 
be used as fillers: 
Influenza (also known as “Flu”):  Base Rate = 350/1,000 (Chin, 2000) and immunization 
effectiveness = 800/1,000 are protected (Isada, 2000) 
Hepatitis A: Base Rate (estimate based on Atkinson, Hamborsky, McIntyre & Wolfe, 
2006) = 330/1,000 and immunization effectiveness = 950/1,000 are protected (Atkinson, 
et al. 2006) 
Tarsallis (a hypothetical disease): Base Rate = 150/1,000 and immunization effectiveness 
= 900/1,000 
 
These three disease/immunization combinations do not fit into the design of the experiment and 
were not be a part of the analysis.  However, it was anticipated that response to them would be 
consistent with probability information displayed.  Table 6.2 shows how controls on design fit 
within the overall matrix of disease base rates by immunization efficacy.  Controls are in bold 
and can be seen to represent three levels of shot efficacy and are intermediate between the 
second and third levels of disease base rates. 
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Table 6.2 Design control stimuli fit into the stimulus matrix 
Stimuli used as controls on design are seen in bold and hypothetical stimuli are italicized. 
 
Shot Efficacy 
Disease Base 
Rate 
50/1,000 
Disease Base 
Rate 
150/1,000 
Disease Base 
Rate 
330/1,000 
Disease Base 
Rate 
350/1,000 
Disease Base Rate 
900/1,00 
950/1,000  
Black Spot 
Fever 
  
Hepatitis A 
 
  
Smallpox 
 
900/1,000  
Hepatitis B 
 
 
Tarsallis 
 
    
Pertussis 
 
800/1,000  
Appalachian 
Pharyngitis 
   
Influenza 
 
 
Chickenpox 
 
 
Presentation format of stimuli were the same as for previous studies (Figure 6.1).  Disease base 
rate was shown first.  Immunization Effectiveness was shown second.  and immunization side 
effect was shown third.  All probability estimates were shown as frequency of event per 1,000 
people. 
 
Figure 6.1 Format for stimuli 
 
 
 
There is a 900/1,000 chance of people without immunization  
getting Smallpox if exposed to it. 
 
The immunization against Smallpox is effective in  
950/1,000 cases. 
 
   However, there is a 1/1,000 chance of a serious side effect of the shot. 
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Replicates:  Two replications of each experiment were conducted with each experiment.  
Two sets of experimental stimuli were printed onto two different packs of cards.  Each set of 
cards were randomized separately so that the entire experiment was conducted once, and then 
again.  Each set of cards was separately randomized.  One replicate was administered, then 
demographics collected and a distracter task1 completed before the second replicate was 
administered. 
Random numbers were obtained for each experiment and arranged in sets for each pack 
of cards for each experiment.  Random.com uses numbers generated from photons from space 
and purports to be a truly random number generator.  Design filler cards were included in the 
randomized card pack.   
Control for Learning Effect:  Since the participants saw each scenario twice, a control to 
test for learning effects was included in the design.  Three cards were always presented first in 
the first pack of cards and last in the last pack of cards.  The learning control stimuli were 
counterbalanced via Latin Square.  
Response:  Connolly and Jeb (2003) note that many of the omission bias studies used 
truncated and/or asymmetrical scales.  The study proposed here used a 10 mm unmarked line 
anchored at each end (Appendix B).  The left end indicated that the participant did not believe 
they would accept an immunization at all under these circumstances.  The right end indicated 
that the participant would always expect to accept an immunization under these circumstances.  
This response format was selected to approximate how a participant might think about 
immunization acceptance. Use of a line scale allowed for intermediate responses rather than 
forcing responses into a fixed-point scale.  Weiss (2006) also notes that a line scale such as this  
 1.  The distracter task is described on p. 70. 
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Reduces participants’ ability to recall previous responses.  There was a separate line with 
anchors for each stimulus card along with a place to write in the code for the card to which the 
participant was responding. Scoring of responses was accomplished by measuring where the 
participant placed a mark crossing the response line. 
Demographics: Participants were asked to complete a demographics questionnaire 
(Appendix C). Demographic information included age, ethnicity, whether or not the participant 
had children, any healthcare experience or chronic diseases and experience with immunizations. 
As described under participant description above, healthcare training was divided into three 
categories: No healthcare training, lay training, and professional training.   
Lay training in healthcare included people who were trained as lifeguards, veterinary 
assistants, or were in pre-healthcare professional classes or otherwise were minimally trained and 
minimally experienced with healthcare issues, such as disease and treatment.  This category was 
thought to represent people who had some exposure to the variables of disease and possibly 
immunization, largely through classes or just being around providers, but did not have a 
professional level of experience.  The “no healthcare training and lay healthcare training groups 
included participants from both the traditional and non-traditional student groups. 
Professional training included licensure as a Certified Nursing Assistant, having been in 
medical, nursing, or veterinary school, or currently working in healthcare.  Participants in this 
group were all in the non-traditional student group.  In addition to being around the sick and 
witnessing death from disease, healthcare providers are required to accept immunization against 
various diseases to protect them from diseases in the patients for whom they provide care and to 
protect these vulnerable patients from diseases that the healthcare provider might bring to work. 
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Distracter task:  In order to reduce participants’ memory for initial responses to the 
primary task, a distracter task was administered (Appendix F). This task is a simple decision task 
asking for an estimation of a nurse’s competence with and without use of a decision aid.  The 
response scale was the similar to that used for the primary task, but with appropriate anchors.   
The distracter task is similar to the experimental task in that participants were given a 
scenario and responded with an estimate made on a line scale as in the experimental task.  Also, 
the task was somewhat related in that it asked for judgment about a healthcare professional.  
However, it is different in that the scenario description was longer and focused on an entirely 
unrelated judgment.  At least one participant reported during debriefing that they thought the 
distracter task was part of the experiment.   
Post Experiment Interview:  After all data was collected, each participant completed a 
post experiment interview form (Appendix D) asking about the strategy they used for their 
decisions and for their suggestions about the experiment.  This form also asked for an estimate of 
the participant’s own assessment of the probability of getting each of the diseases used in the 
experiment.  Both the actual diseases and hypothetical diseases were included.  The inclusion of 
hypothetical diseases allowed for inference of the degree to which participants were aware that 
these were hypothetical diseases, i.e. if a participant states they are likely to get a hypothetical 
disease, it can be inferred that they believe the disease could be real. After this form was 
completed, it was reviewed with the participant.  They were asked to clarify any comments and 
add other comments they wished so that each participant was given a chance to clarify with the 
investigator how they approached the experiment and thought about the tasks. 
Debrief:  A debriefing statement (Appendix E) concluded the experiment with an 
explanation of the experiment and how it contributes to our knowledge of decisions made about 
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coping with disease and immunizations.  Any information that might be unclear to participants 
about actual disease and immunization probabilities were clarified to ensure that participants 
were not inadvertently misled by any component of the experiment.   The latest information on 
actual diseases and their probability as well as vaccine efficacy was provided as part of this 
debrief.  Participants were allowed to keep this debriefing statement. 
Protocol:  Participants were administered the experiment individually.  Nearly all 
participants finished the experiment in 45 minutes or less.  All materials used by each participant 
were presented together in a folder.  Participants were first given an overview of the experiment 
(App. G).  They then signed an informed consent form (Appendix H).  The consent was 
immediately separated from all other data and is stored in a locked file to be maintained for three 
years after the experiment.   
Participants were instructed on experimental procedure.  They were provided one set of 
the experimental stimuli as described above (see stimuli).  They responded to each stimulus card, 
one at a time, by marking their estimates on the answer sheet provided (Appendix B), indicating 
likelihood of accepting an immunization under the circumstances shown on the card.  
When participants completed one set of stimuli for the experiment, they were asked to fill 
out the demographic form (Appendix C), and then completed a distracter task (Appendix F) as 
described above.  Participants then completed the second replication of the experiment. 
After the second replication of the experiment was completed, participants went through 
the post experiment interview (Appendix D) as described above.  They were then given 
debriefing information (Appendix E).  They were informed at that time which diseases are 
hypothetical.  They were allowed to keep the information from this debrief.  All participant 
questions were answered prior to their exit of the experiment.   
  
72
Analysis:  Initial analyses were conducted using CalStat (Weiss, 2005), a statistical 
software package for performing functional measurement.  Functional measurement was used to 
identify significant variables, describe the nature of the interaction of those variables, and to 
examine how individuals contributed to the overall result.  Since group analysis provides only a 
summary of how people behave and does not reflect individual differences, analysis was 
conducted at both the individual and the group level.  After data were examined using functional 
measurement, a repeated measure ANOVA was used to examine how demographic variables 
might relate to the results.   
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CHAPTER 7 -  Results 
 
Hypothetical vs. Real Disease Names: Since hypothetical diseases were not uniformly 
distributed through out the design, direct comparison of response to hypothetical vs real diseases 
could not be statistically tested.  Participants did indicate, however, that there was some 
likelihood of contracting each of the diseases presented, regardless of whether or not it was a real 
or hypothetical disease.  The question asked in the post experiment interview was how likely the 
participant would be to get that disease.  Participants indicated that, although they might get the 
disease, if they had not heard of it, they were less likely to be exposed.  They did not indicate 
having seriously considered whether or not the disease was real.  Many expressed surprise at the 
question of which diseases they thought were real, suggesting they thought all were real.  They 
indicated that they interpreted the question of which diseases were “real” to indicate which ones 
they had heard of.   
Many of the participants indicated that they were considering whether they would be 
likely to be exposed to each of the diseases as part of their decision strategy.  In this light, it is 
interesting that participants responded to Smallpox as if they might be exposed to it.  Participants 
in this series of experiments have been uniformly willing to accept Smallpox immunization in 
line with its disease base rate.  The data shows that participants are nearly as likely to accept 
immunization against the hypothetical disease of Fibrilosis as they are against the real disease of 
Smallpox and as likely to accept immunization against the hypothetical disease of Verde’s 
Disease as they are the real disease of Bacterial Meningitis.  Indeed, participants are more likely 
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to accept an immunization against the hypothetical disease of Appalachian Pharyngitis than they 
are the real disease of Pneumonia.   
Some participants reported that they were unfamiliar with the disease of Pertussis until, 
during debriefing, it was identified by its more common name of Whooping Cough.  Thus, the 
response to Pertussis for many was the same as it would have been with a hypothetical disease.  
Nonetheless, participants were more willing to accept an immunization against Pertussis (which 
had a higher base rate and the same shot efficacy) than against a disease they all recognized, 
Hepatitis B, which had a lower base rate and the same shot efficacy. The fact that participants 
responded as expected to Pertussis, in spite of failure to recognize the disease by that name 
suggests that use of hypothetical disease names did not influence results.   
However, personal beliefs about the familiar diseases may have influenced decisions.  
The data do suggest that likelihoods for both disease and immunization did significantly 
influence decisions in spite of whether or not the disease name was familiar.  Some participants 
reported considering how likely they thought they might be to get a particular disease in addition 
to considering the variables presented in the stimuli, although this influence seems not to be 
systematic.  Methods of limiting this framing of the variables in future experiments will be 
discussed below. 
Results of Control on Design:  The pattern of response to the design controls was 
consistent with that for the rest of the design (Figure 7.1).  Design controls are shown in Figure 
7.1 as individual points on the graph.  Lines connect variables used in the study design.  Results 
for the experimental variables will be discussed later.  Overall, with the exception of Hepatitis B, 
to be discussed later, participants appear to have responded to probability statements in both the 
target and control stimuli rather than to the specific disease names. 
Figure 7.1 Design Controls with Disease Base Rates by Shot Efficacy for rest of design 
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ShtEff 999/1,000= shot efficacy of 99%; ShtEff 950/l,000= shot efficacy of 95%; ShtEff 900/1,000= shot efficacy of 
90% and ShtEff 800/1,000= shot efficacy of 80% 
Disease base rate 1/1,000 (blue diamond), disease base rate 50/1,000 (dotted line with square), disease base rate 
150/1,000 (green triangle), disease base rate 330/1,000 (large black X), disease base rate 350/1,000 (small dark 
asterisk), and disease base rate 900/1,000 (dark circle: top line). Disease base rates 150, 330 and 350 are results for 
each of the design control stimuli.  Each of these results are single point entries with no line on the graph.  These 
results are consistent with what would be expected if participants attend to probability statements in each scenario.  
Results for the design control stimuli fit well with overall results of the experiment. 
Results of Learning Control:  The question of adaptation or fatigue resulting from 
multiple presentations of the stimuli was addressed by placing three test stimuli at the beginning 
of the first pack of cards and the same three stimuli at the end of the second pack of cards.  There 
was a significant (F (1, 57) = 27.394, p < .001, η2 = .325) overall reduction in likelihood of 
 
 
75
immunization with replication of the stimuli.  Effect of replicates can be seen in Figure 7.2.  The 
question to be asked is: What was learned?   
It may be that, with replication of the stimuli, participants began mentally comparing 
stimuli to one another and adjusting their likelihood estimates downward with experience.   If 
Figure 7.2 Learning Effect 
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A significant effect of experience with the stimuli was found.  In general,  
participants were less likely to accept immunization with a second replication 
of the stimuli. 
 
that is the case, participants may not be looking at each immunization decision in isolation, but 
rather they may be comparing variables from one situation to another, at least in a general way.  
Perhaps the participants are asking themselves: “How bad is this disease compared to the others 
I’ve seen?”  This would seem to be a normal adaptation process.  Perhaps this is similar to the 
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well-known effect of habituation where the contrast is more salient with repeated exposure to 
immunization.  Further exploration of this possibility is warranted. 
Individual Analysis:  Functional measurement is based on initial individual analysis of 
decision rules.  It must be recognized that power is very low when looking at only two 
replications (the number for each individual in this study).  There is considerable variation 
between individuals. Figure 7.3 shows the percent of individual participants who demonstrated 
significant main effects and interactions, grouped by patterns of results.  As can be seen, the two 
largest categories by far were for participants with only a main effect for disease base rates. 
Figure 7.3 Percent of individuals with significant effects by category of effect pattern 
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Figure 7.4 shows the pattern of results typical of these participants.   As can be seen, 42% of 
participants focused only on disease base rates, ignoring immunization efficacy and neglecting to 
integrate the two pieces of information together.  This is consistent with the large effect size seen 
for this variable across previous experiments (Experiments #1-#5).  However, in those studies, 
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disease type encompassed disease base rate, disease severity, immunization side effect 
probabilities and immunization efficacy, which vary from disease to disease.   
In this study, this effect is further clarified, showing that disease base rates account for much of 
this effect.  Clearly, the variable that is most predictive of immunization behavior by most people 
is whether or not a disease is likely.  Anecdotal illustrations of this are easy to obtain.  Some 
illustrations of this were discussed in the chapters on theoretical background. 
Figure 7.4 Typical pattern for individuals with only significant effect of disease base rates 
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 There were a large number of individuals who had significant main effects for both 
variables and a significant interaction.   Figure 7.5 shows the functional measurement pattern 
typical of these participants.  As can be seen, when main effects are both significant and there is 
also a significant interaction, the picture is more difficult to interpret.  In the present study, the 
interaction appears to involve shot efficacies of 99% and 80%, primarily with disease base rates  
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Figure 7.5 Typical pattern for individuals with significant main effects and significant 
interaction 
Disease Base Rates x Shot Efficacy Part #7 (Both 
ME and Interaction Significant)
0
10
20
30
40
50
60
70
80
90
100
DBR 1/1,000 DBR 50/1,000 DBR 900/1,000
Disease Base Rates
Li
ke
lih
oo
d 
of
 S
ho
t
Sht Eff 99%
Sht Eff 95%
Sht Eff 90%
Sht Eff 80%
 
 
of 1/1,000 and 900/1,000.    These are the extremes of these two variables.  In the example 
shown here, it appears that when there is a high shot efficacy, this individual would likely get a 
shot if the disease was either very unlikely or very likely.  When there was a very low shot 
efficacy, this individual was about 50% likely to get if the disease was unlikely and only 10% 
likely to get the shot if the disease was very likely.  These extreme variations are very difficult to 
explain.  The responses to the middle shot efficacies appear to be nearly identical to each other 
and similar to the response to disease base rate alone, seen in figure 7. 4.    
There were also participants who showed significant main effects, but no interaction 
between disease base rates and shot efficacy (Figure 7.6).  In this case, interpretation is easier.  It 
is clear that disease base rates have an effect, with a general increase in willingness to accept 
immunization when base rates are high.  However, there is much more willingness to accept 
immunization when shots are effective.  Like Figure 7.5, shot efficacies of 99% and 80% show 
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much more variation than do shot efficacies of 95% and 90%.  Also, this individual is overall 
less than 50% willing to accept immunization under any circumstance. 
 
Figure 7.6 Typical pattern for individuals with only significant main effects and no 
significant interaction 
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However, 9% of individuals have no significant result.  An example of the pattern of 
results seen for these individuals is shown in Figure 7.7.  As can be seen, for this individual, 
interpretations of the results are difficult.    This individual essentially answered with a high 
willingness to accept immunization in nearly all situations.  While there is some variation, there 
is no distinct pattern. 
Since functional measurement is the examination of the integration of two variables, this 
method is dependent on examining interactions.  Individually, not quite half of participants 
demonstrated a significant interaction between disease base rate and immunization efficacy, as 
can be seen in Figure 7.8.  This likely reflects the lower number of participants for whom  
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Figure 7.7 Typical pattern for individuals with no significant results 
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Figure 7.8 Percentage of individuals who showed a significant interaction between disease 
base rates and shot efficacy. 
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immunization efficacy influenced decision-making as well as low power for each individual.   
Clearly, there is considerable variation between participants in their response to the variables, 
except in the case of disease base rates. However, when pooled together individual differences in 
patterns of response can be masked.  Nearly all individuals were influenced by disease 
likelihood.  A little less than half were influenced by immunization effectiveness.  There was a 
significant interaction between disease base rates and shot efficacy for just under half the 
participants. Since less than half of participants showed an interaction between the two variables, 
group data should be interpreted cautiously.    With individual differences in mind, a group 
analysis was undertaken to examine overall trends in immunization decisions in response to the 
variables. 
Group analysis:  As expected, on the group level of analysis, there was a significant main 
effect of disease base rates (F (2,114) = 131.67, p < .001, η2 = .70).  The effect size is consistent 
with that found in earlier studies, so this is clearly a replicable effect.  More than 60% of the 
variance is explained by the effect of disease base rates.   
There was also a significant main effect of Shot Efficacy (F (3,171) = 12.73, p < .001, η2 
= .19).  The effect size was much smaller for main effect of immunization efficacy (.19) than for 
disease base rates (.70).   More importantly, interaction between disease base rates and shot 
efficacy was also significant (F (6,342) = 20.11, P < .001, η2 = .27).    This is consistent with 
earlier studies.  The effect of shot efficacy is much better understood in light of disease base 
rates.  The interaction between these two variables explains more than 25% of the variance in 
immunization behavior.  This interaction is illustrated in Figure 7.9.  The Linear-by-Linear 
contrast for the interaction is not significant.  When the linear-by-Linear contrast is not 
significant, this rules out a multiplicative model.   Highly contagious diseases, whether real 
(Smallpox, Pertussis and Chickenpox) or hypothetical (Fibrilosis), appear to increase likelihood 
of immunization acceptance over less infectious diseases.  Shot efficacy also impacts decisions, 
but to a lesser degree.   There appears to be some suggestion of a systematic change in likelihood 
of immunization from the lowest level (1/1,000) of disease base rate to the next higher level of 
disease base rate (50/1,000) for all levels of shot efficacy.  At 50/1,000 disease base rate, 
immunization efficacy appears not to matter at all.  However, when disease base rate becomes 
very high, there is a suggestion of a systematic increase in interaction with shot efficacy.  
However, the fact that levels of both variables are not equally spaced may have affected the 
ability to identify clear patterns in the results. 
Figure 7.9 Group results for functional measurement of disease base rates x shot efficacy 
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The results show an unexpected spike in response to the cell containing the probabilities 
associated with Hepatitis B.  Exactly why this is the case is unknown.  However, it is known that 
there are current campaigns to immunize various groups, including college students, against 
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Hepatitis B.  It is possible that current immunization campaigns targeting college students and 
suggesting all students be immunized against Hepatitis B, familiar to the participants in 
this study, made this disease more salient than would otherwise be the case.   This possibility 
could be examined by replicating the study with a population who had not been recently targeted 
in an immunization campaign.  Another method of checking would be to change all disease 
names to a hypothetical name and examine the resulting pattern or response. 
It should be remembered that, since the design was based on disease base rates and 
immunization effectiveness from real diseases (with fillers to complete the matrix), the design 
was constrained by these realities.  It appears that, overall, the effect of disease base rates is the 
most important effect. 
Some participants said that there was not much difference between levels 1 and 2 of 
Disease Base Rates.  The increase from 1/1,000 to 50/1,000 (levels 1 and 2 of Disease Base 
Rates) may appear small in comparison to 900/1,000 (level 3 of this variable).   In fact, there is a 
50 fold (1 x 50) increase between level 1 and level 2 of disease base rate, which across the 
population of a city of 40,000, would translate to an increase from 40 cases (1/1,000) to 2,000 
cases (50/1,000).  Participants can more easily understand the impact of the larger percentage 
(900/1,000 =36,000 cases in a city of 40,000), especially in comparison to the smaller numbers.  
This issue will be further examined in the discussion section. 
Although participants were not asked directly for their interpretation of shot efficacy, 
their response to 1/1,000 and 50/1,000 disease base rates was very similar.  They appear not to 
recognize that an immunization only protects that segment of the population who would have 
gotten the disease if they did not get the immunization.  That segment is computed from the 
disease base rate rather than from the overall population.  Thus, if the disease base rate is 
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50/1,000, and shot efficacy is 900/1,000, shot efficacy translates to a disease rate reduction of 
45/1,000 from the original 50/1,000.  5/1,000 would likely still get the disease after being 
immunized (a reduction from 50/1,000 to 5/1,000).  None of the participants appeared to have 
done this kind of calculation.  This is an important issue.   Follow up exploration of this 
possibility will be discussed below. 
Individual differences based on demographics:  Individual difference variables may be 
helpful in identifying how participants were influenced by factors other than the variables on 
which this study focused.  Pilot studies suggested that demographic factors such as age, gender, 
parenthood status, training as a healthcare provider or personal health factors may influence 
decisions about accepting immunization.  Although these variables were not the focus of this 
study, results of post hoc analyses of these variables may suggest directions for future research.  
Only gender (in interaction with the two independent variables), parenthood status and health 
care training yielded interesting results. 
  Age of participant may be a marker for life experience with the variables of interest.  
Participants were divided into two age categories: traditional college student (N = 31, age range 
18-21, Mean =19) and non-traditional student (N = 27, age range 24-62, Mean 36.44).  There 
was no significant effect of age on immunization decision-making (F (1, 56) = .494, p = .485, η2 
= .009).  However, specific life experiences might play a bigger role in immunization decision-
making. 
Gender is an individual difference variable that may also be a marker for different 
experiences.  Therefore, gender was examined to see if this variable could predict differences in 
immunization decision-making.  Eighteen male students and forty female students participated in 
the study.  There was no main effect of Gender on immunization decisions (F (1, 56) = .738, p = 
.394, η2 = .013).   However, there is a three-way interaction between gender and the two primary 
variables of disease base rates and immunization effectiveness (F (6,336) = 2.734, p < .05, η2 = 
.047).  Figures 7.10 and 7.11 show that the general pattern of response is similar for both  
Figure 7.10 Disease Base Rates by Immunization Efficacy for Males 
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Figure 7.11 Disease Base Rates by Immunization Efficacy for Females 
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genders, but the magnitude is greater for females at the lowest level of disease base rate and at  
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the highest level of disease base rate.  It appears that females may be a little more likely to accept 
immunization than males.  Males appear to be more likely to accept immunization when shot 
efficacy is high (99%) and disease likelihood is low (1/1,000).  Females appear to be more likely 
to accept immunization when disease likelihood is high, regardless of immunization efficacy.  
This apparent interaction deserves further study. 
Most parents would agree that having a child changes one’s perspective on life.  This 
change may include how one views such preventive medicine decisions as immunization.  
Therefore, whether or not a participant had at least one child (of any age) was examined to see if 
this might contribute to prediction of immunization decisions.  Fourteen participants reported 
having at least one child and forty-four reported no children.  Children ranged in age from 
toddlers to adults in their 30s.  There was no significant effect of being a parent on likelihood of 
accepting immunization for oneself.  (F (1, 56) = 3.262, p = .076, η2 = .055) and there was no 
interaction between this variable and any of the other variables.  However, with a more balanced 
pool of participants (half parents of dependent children and half not parents) this variable might 
be shown to have a significant effect.   
An earlier pilot study suggested that people training in healthcare provider experience 
may view immunizations with less skepticism or may view disease with more fear than the 
general public.  Therefore, experience and training in healthcare was collected as a demographic 
variable.  Healthcare experience was divided into three categories.  No experience at all (N = 
41), lay experience (N = 12), and professional experience (N = 5).   
The professional healthcare provider group included people with nurses’ training, one 
person with medical school training, a person with veterinary medicine training and others with 
similar professional training including being a certified nursing assistant.  There was a 
significant effect of healthcare experience (F (2,55) = 3.181, p < .05, η2 = .104).  As can be seen 
in Figure 7.12, this effect was entirely due to an increase likelihood of accepting immunization if 
the participant had professional healthcare experience.  The fact that significant results, with a 
moderate effect size was obtained with such a small number of participants in the health care 
professional category suggests that this variable is worth further study. 
 
Figure 7.12 Main effect of healthcare training on likelihood of immunization acceptance. 
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CHAPTER 8 -  Limitations 
 
There are a number of limitations to this study.  First, it should be remembered that 
participants were in a lab setting.  An effort was made to include accurate information in 
designing this experiment.  However, this experiment remains artificial in that participants are 
only presented with information about disease and immunization frequencies and are asked to 
make an estimate of their likelihood of accepting an immunization.  They are not given 
background information about the situation.  They are also not actually making the decision to 
accept or reject a real immunization, since the experiment is done in a lab setting.  However, the 
fact that there were main effects and interactions that were replicable over several experiments 
and which had large effect sizes is encouraging.   It remains unknown whether these finding will 
generalize to a situation in which one is faced with a real disease and offered a real 
immunization.    
Secondly, only one interaction between disease (disease base rates) and one 
immunization variable (effectiveness) are explored in Experiment #6.  The initial experiments 
explored more of the variables from the HBM.  There are several interesting interactions that 
deserve more study.  These include disease severity and disease base rates, disease severity and 
immunization efficacy to name a few.  Although immunization side effects are limited in 
statistical impact in the designs used for this series of studies, this variable is one reliably 
identified as a factor in qualitative research on immunization.  Therefore, this variable also 
should be further studied.  The discussion section discusses this variable in more depth.  Other 
variables, such as cost, the individual’s physical condition and environmental variables such as 
season could also be included in future designs.  The disease base rates used for the present study 
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were averaged across some of these other variables.  If base rates were made more situation 
specific, this would likely affect individual decisions in those situations.  How such situational 
and personal variables interact should be explored.  
If one is to systematically manipulate the variables in a laboratory experiment, the 
number of variables used must be limited.  To do otherwise would be to confuse participants.  
Therefore, after extensive initial testing, the selected variables were examined systematically.  
These results do not preclude the possibility that other variables influence immunization 
decision-making.  However, these studies suggest that the ones used in the final study are key 
variables. 
Numerous survey studies of immunization beliefs suggest that many variables can 
influence actual acceptance of medical advice to immunize.   These include the advice of peers, 
the advice of trusted (and trust of) medical personnel, and personal or vicarious experience with 
disease or immunization.  Analysis of demographic variables suggests that medical training and 
being the parent of a child also impacts willingness to be immunized.  Other demographic 
variables, such as age and gender and ethnicity were not significantly linked to immunization 
decisions in this study.   
Age groups in this study were nearly equally divided between younger, traditional 
students and older, non-traditional students.  Results suggest that age by itself does not 
significantly affect likelihood of immunization acceptance.  However, age does reflect certain 
kinds of experience, such as becoming a parent or engaging in training and practice of 
healthcare.   Therefore, it is worthwhile to recruit non-traditional participants for future studies of 
immunization decisions. 
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Healthcare training appears to increase immunization acceptance.  Healthcare training 
influences likelihood of immunization acceptance only if the individual has substantial formal 
healthcare training.   Unfortunately, the number of participants in this study who were formally 
trained in healthcare was small.   It seems important to explore this effect further.   
There was a small group of participants who were parents.  The fact that there was a near 
significant result for this group suggests that the effect of parenthood on immunization decisions 
made by a parent for himself or herself should be further explored with a more targeted study. 
The majority of participants were Caucasian.  Little can be inferred about immunization 
decision making in other ethnic groups based on this study.  It may be that there would be little 
difference in factors influencing immunization decisions between this, largely Caucasian group 
and groups of other ethnicities.  Discovering any difference based on ethnicity would require a 
study targeting ethnic minorities in numbers large enough for a valid comparison.   
Socio-economic status of participants in this study was obviously high enough that they 
were able to attend college.   It is unknown to what extent results might be generalizable to other 
socio-economic groups.  
As noted in the method section, the probabilities used for this study are fixed.  In 
actuality, probability of disease is affected by numerous variables including host immunity, 
organism virulence and vector factors, and life style behaviors.   Immunization effectiveness is 
likewise not a straightforward probability.  However, for the purpose of decomposing the 
problem and identifying how these variables affect immunization decision-making, it is useful to 
present them as fixed numbers. 
There appear to be various framing effects in the display of information to the decision 
maker.  Only one frame of reference was used for the final study.  As noted in discussion of 
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framing effects, exploration of how information is presented may increase magnitude of 
likelihood of accepting immunization.  However, it does not appear to affect the pattern of 
response to different variable values relative to response to other variable values.  If it has any 
effect, it is just to increase all responses uniformly.  This is an issue of risk communication and 
should be further explored. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
93
CHAPTER 9 -  General Discussion 
 
Economic Theory has been attractive as a model of decision making largely because of 
the ability to mathematically model options and clearly determine the best choice.  However, this 
is unlikely to reflect how people think.  No amount of training in EV, EU, or SEU will enable 
people to choose one correct option every time in every real world situation.  This is especially 
true when the environment in which the decision maker is working is dynamic with time 
pressured or when the decision is unique with little opportunity to even identify all the potential 
payoffs, let alone estimate probabilities.  Therefore, although Economic Theory may be useful in 
recommending decision strategies in some situations, it is not useful in understanding most 
situations.  Therefore, Economic Theory is ill suited for the study of immunization decisions. 
The focus of the Heuristics and Biases approach has been to identify thinking errors that 
lead to poor decision making.  Omission Bias (Ritov & Baron, 1990) in particular has been used 
to describe immunization decision-making.  However, there are two problems with this 
approach.  In the first place, this description of immunization behavior is little more than a 
recitation of the well-known medical edict to “do no harm”.  In the second place, the 
methodology used has been called into question (Connolly & Reb, 2003).  While the heuristics 
and biases literature tends to use artificial scenarios (e.g. “600 will be saved and 200 will die”), 
the present study used more representative scenarios developed from careful review of the 
medical literature.  While the study of heuristics and biases may be useful in terms of showing 
pitfalls to be avoided, it has not proved helpful in improving decision making in everyday 
situations.   In fact, base rate neglect, a principle finding in the heuristics and biases literature, is 
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not found in the present study.  It may be that the finding of base rate neglect is an artifact of the 
design of most Heuristics and Biases studies. 
Gigerenzer and Selten (1999) offer an alternative to heuristics and biases by describing 
heuristics that are adaptive.  Although this is much closer to the approach that Simon (1956) had 
in mind, it still fails to provide useful guidance in many situations.  Fast and Frugal Heuristics 
(F&F) (Gigerenzer & Selten, 1999) can be described, but do not provide for generalizable 
knowledge of how to identify exactly which key variables to include for best results.   The results 
of this study, however, suggest that one variable, disease base rates, appears to dominate 
immunization decision-making.  This lends strong support to the F & F model of decision-
making. 
Hammond’s Lens Model (2000) recognizes the need to select ecologically valid stimuli 
by carefully assessing the cues in the environment in which the participant will make a decision.  
However, this model assumes, but does not test for, how these cues are cognitively combined to 
make a decision.  Although this is a useful model, it is not consistent with systematic 
manipulation of variables as would be done in a factorial design. 
The HBM (Rosenstock, 1974) is descriptive without any quantitative data to provide 
reliable predictive power. This model has considerable face validity.  It is used extensively in 
some areas of medical decision-making.  However it is vague in application.  Each researcher 
seems to add to or subtract from the model and to make ad hoc interpretations of results.  The 
HBM appears to be useful in generally identifying variables for further study.  The present study 
takes the HBM from a qualitative model and begins to develop a quantitative model of health 
behavior. 
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 Each of these approaches adds something to the understanding of decision-making.  But, 
like the blind men and the elephant, each reveals only one part of the whole picture.  One way to 
get a better handle on the problem is to combine approaches to both identify key variables that 
influence decision-making and to quantify their contribution.  None of the experimental 
approaches appear to accommodate inclusion of other approaches, such as the HBM.   
Functional Measurement, (Anderson, 1981) offers a way to use the findings of the HBM 
to not only identify which information contributes to the decision, but also to determine how that 
information is cognitively combined to make a decision.  By using FM to examine the interaction 
of HBM variables and by using ecologically valid stimuli as suggested by Hammond (2000), a 
step can be taken toward the goal of predicting immunization behavior under different 
circumstances. 
Results of early studies suggest that there is a reliable effect of disease factors such as 
severity and base rate as well as a reliable effect of immunization efficacy on immunization 
acceptance.  These findings are consistent with both the survey literature from medicine and with 
the HBM (Becker, 1974).  Immunization side effects appear to significantly affect immunization 
decisions only when they are most severe.  The main effect of immunization side effect severity 
is not significant when immunization efficacy is systematically manipulated.   
The finding that manipulation of immunization efficacy resulted in no main effect of 
immunization side effect severity was surprising.  Qualitative studied generally have supported 
immunization side effect as a reason given for avoiding immunization.  There are several reasons 
that might explain the present finding.  First, qualitative data does not explore interaction of 
variables.  When other variables are systematically manipulated, immunization side effects 
  
96
interact with some of those variables, most notably, with disease base rate and disease severity.  
It seems likely that this interaction might be important to explore.   
The swine flu epidemic in 1976 provides an good example of how this interaction might 
work.  In that year, preventive medicine authorities predicted an epidemic of an unusually deadly 
strain of influenza.  They provided a flu shot to prevent infection and launched an extensive 
information campaign to encourage individuals to get that immunization.   Early in the flu 
season, however, reports began to be published about an unusual and very serious side effect 
from the immunization again swine flu, Guillian-Barre Syndrome.  Shortly after those reports 
surfaced, the rate of immunization fell off sharply and the government ceased its immunization 
campaign for the general public.   Side effects of the Swine Flu shot have been cited as the 
reason for this public health debacle.  The fact that is less reported is that, at the same time that 
serious side effects were being reported, the actual rate and seriousness of flu was found to be 
much less than had been forecast.    Therefore, it is possible that the failure of the Swine Flu 
campaign is due to an interaction of disease factors and immunization side effects rather than a 
main effect of immunization side effects.  Exploration of this interaction may therefore much 
more important than exploration of side effects alone. 
Overall, the variable of disease type seems to contribute the largest amount of the 
variance in immunization decisions.  More importantly, this variable interacts reliably with the 
other variables in the HBM.  Exploration of these interactions may provide predictive power to 
the HBM. 
Experiment #6 is based on analyzing the interaction between disease base rates with 
immunization efficacy.  This interaction is significant and has an appreciable effect size (η2 = 
.267).  Thus, the effect is not additive.  However, the linear by linear contrast for this interaction 
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is not significant.  This suggests the integration rule used by participants is more complex than a 
multiplicative model for the integration of the two variables.  There is a significant residual.   
This residual suggests the complexity of the integration rule, but does not specify a model.  
Without specification of the integration rule, development of a scale for the variables can’t be 
accomplished.    
There appears to be an overall clustering of immunization acceptance below 50% (range 
35.81 - 46.98) for the lowest level of disease base rates, a clustering  (40-60) around 50% for the 
next higher level of disease base rate, and a clustering of immunization acceptance above 50% 
(range 66.68 - 79.75) for the highest level of disease base rates.  The interaction of these two 
variables, while significant, appears not to be nearly as important as disease base rates.  The 
threshold for significant impact of disease likelihood in immunization acceptance may be the 
most important issue.  Variables that interact with disease base rates appear to interact, but the 
impact of those variables is small.  One could compare the impact of disease base rates to 
immunization efficacy as the difference between an elephant and a mouse. 
However, there is one case in the final study that has an unusually large increase not 
characteristic of the general pattern seen for the interaction.  This cell is the one for Hepatitis B.  
It may be that, since participants were all college students and that there is a campaign targeting 
college students to accept immunization against this disease, these participants believed they 
were particularly vulnerable to Hepatitis B.   Results for Hepatitis B for this particular study are 
consistent with the article (Practice Notes, 2004) describing an all out flu immunization 
campaign that greatly increased flu immunization in one Health Maintenance Organization for 
one year.  However, whether or not the effects of such a campaign would generalize to other 
years or other immunization has not been tested.  The results found in this study can be examined 
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by replicating the experiment with a different population.  Other than the response to Hepatitis B, 
the pattern of response suggests that there is a general additive effect of shot efficacy and to 
disease base rates.   
The present series of studies develops a methodology for careful examination of the 
variables of the HBM (Rosenstock, 1974) using a representative design (Hammond, 2000) to 
identify how variables are cognitively integrated (Anderson, 1974) to predict behavior in an 
immunization decision.  Using this methodology, the HBM (Rosenstock, 1974) can be modified 
to predict as well as describe behavior. 
Research based on this approach can suggest ways in which both patient education and 
decision support materials can be developed.  For instance, the finding that participants did not 
find a noticeable difference between the 1/1,000 and 50/1,000 levels of disease base rate suggests 
that a decision support program might place these likelihood estimates within a context familiar 
to the individual, such as “in a city of 40,000, 40 would get this disease” (for 1/1,000) or “in a 
city of 40,000, 2,000 would get this disease” (for 50/1,000).  Other methods of providing 
immunization effectiveness information might be: (1) telling subjects the relative reduction in 
disease base rates to expect from an immunization (e.g. “reduce the relative likelihood of disease 
from 900 to 50”), (2) report the absolute reduction in disease base rates due to immunization 
(e.g. “a reduction of 850 people”), (3) report shot efficacy as a ratio (e.g. “only 50/900 people 
exposed will get the disease, if they are vaccinated”). Decision tools to help people make better-
informed decisions might be developed using the present approach to identify how display 
information about the disease and immunization affect decisions. 
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CHAPTER 10 -  Summary 
This series of studies call into question how the HBM is viewed.  It appears from these 
results that decision makers do not equally weight all of the variables in the HBM.  Specifically, 
disease base rates appear to explain the largest amount of variance.  This is a robust effect.  
Immunization efficacy appears to be more important than immunization side effects.  
Immunization efficacy cannot be interpreted by itself, but interacts additively with disease 
likelihood.  Previous experiments indicate that disease severity is important primarily because of 
its interaction with other disease variables such as shot efficacy. This deserves further attention. 
The only demographic variables that appeared to have an effect on results were gender 
and professional healthcare training.  There was a suggestion that parenthood might increase 
likelihood of accepting immunization, but the number of participants in this category was small 
and the results did not reach significance at the .05 level. 
The major contribution of this study is the development of a methodology that takes the 
HBM (Rosenstock, 1974) beyond a description of variables influencing healthcare decisions to 
enable development of predictive models of health behavior.   This method uses stimuli from a 
representative design (Hammond, 2000), but goes beyond the Lens Model approach.  Use of a 
representative design provided generalizability.  Use of a factorial design and examination of the 
nature of significant interaction using FM as described by Anderson (1974) provides predictive 
power.   
Using the experimental approach developed here, other interactions between disease 
variables can be explored.  One important question that might be asked is: How effective must a 
treatment be in relation to a disease variable for an individual to accept that treatment?  This 
question applies not only to immunization decisions, but also to decisions about other healthcare 
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decisions, such as diabetic management (e.g. tradeoff between disease management strategies 
such as diet changes and complication avoidance) and cancer treatment decisions (e.g. how much 
chemotherapy side effect will one tolerate in order to “buy” time to live longer).  In health 
maintenance, the present approach could be used to examine people’s diet and/or exercise 
decisions (e.g. what kind of exercise would a person be willing to do under different payment 
distance to facility or time constraint circumstances?).  In the health maintenance arena, it may 
be helpful to use qualitative data on the barriers to healthy behavior and systematically examine 
how each barrier affects diet or exercise behavior. 
 This approach could also be used for decisions outside of healthcare. In business, the 
question could be asked, how much of a profit must be made on a good in order to see it as worth 
manufacturing (tradeoff between cost and sale price).  In military strategy, the question could be 
asked: How much resource should be put into an operation in order to achieve an objective? 
(Tradeoff between sacrifice and military goals). 
In general, it is useful to not only identify the variables that appear to influence decisions, 
but also to explore how those variables interact.  Knowledge of the interaction can help both with 
understanding behavior and with design of effective decision aides.  The present study 
demonstrates one way to combine previous research findings to develop an approach to 
answering those questions. 
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Appendix A - Immunity and Types of Immunization 
 
Immunization is an invasive medical procedure aimed at preventing an individual from 
being infected by a disease.  It is invasive because it puts a foreign substance into the body.  The 
body has two primary mechanisms for fighting infectious disease:  cellular immunity and 
humoral immunity.   Cellular immunity is accomplished by what are commonly called the white 
blood cells, but is initiated primarily by the T family of lymphocytes (a type of white blood cell).  
Cellular immunity includes the memory component of immunity.  That is, the ability of the body 
to recognize a foreign substance to which it has reacted in the past.  Humoral immunity is 
noncellular substances such as antibodies produced by interaction of B and T lymphocytes.  The 
whole system of immune defense is complex with several cells interacting to produce substances 
in response to identification of a “non-self” substance in the body.  The procedure of 
immunization takes advantage of the body’s natural responses to the introduction of a foreign 
substance by introducing a non-disease producing substance closely related to the infectious 
organism so that the body learns to identify the disease and rapidly mounts its defenses when the 
actual disease is introduced.  In essence, immunization involves developing a cell based memory 
system to activate defenses against infectious disease (see Appendix A for detail). 
The immune system is a system of cells and cell products that protect the body from 
foreign substances, like germs, via several different actions and through interaction.  There are 
four basic methods of immunization (Mandel, Bennett, and Dolin (2000).  The first method is 
vaccination.  Vaccination is accomplished by introduction of an altered form of an organism to 
prompt an immune response that generalizes to the more virulent form of the organism.    
Vaccination uses on of three methods: 1. live, attenuated organisms, 2. killed organism or a 
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partial form of the organism, such as protein from the organism.  The second method of 
immunization is the use of a toxoid, an attenuated product of the organism.  The third method of 
immunization is use of pooled serum treated to have a high titer of IgG, one of the important 
components of humoral immunity.  This is called “immune globulin”.  The forth method is 
similar to the third, except that it is specifically treated to have a high titer of defense to a 
specific disease, such as rabies.  Use of both vaccination and toxoid administration are 
considered active immunization because both methods induce the body to create it’s own natural 
defense to specific infectious organisms.  Immunglobulin and specific immunglobulin are called 
passive immunization because these methods introduce immune components already generated 
by another host to the disease and do not invoke an immune response in the individual. 
 Health and government personnel have been exploring ways to convince the 
public of the efficacy and safety of immunizations since the smallpox vaccine was first 
introduced in England by Jenner in 1796 (Brannon, 2005).  The response to these efforts has 
been variable.  There is good reason for skepticism on the part of the public.  Although 
introduction of substances into the body to evoke an immune response can prevent serious 
illness, debility and death, the procedure is not without risk.  Hypersensitivity of an individual to 
the immunization substance or to a component of the mixture used to produce or to carry the 
substance is one of the primary risks of immunization. For instance, persons allergic to eggs or 
chickens should not receive immunizations that are manufactured using eggs as a growth 
medium.   However, contamination or inadequate manufacturing procedures can also introduce 
risk.  Persons whose immune systems are not normal for one reason or another also have 
increased risk of adverse responses to immunization.  Healthcare personnel take all these issues 
into consideration when planning and administering immunizations, but unforeseen problems do 
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arise and are the stuff of urban legends, such as the belief that routine childhood immunization is 
responsible for autism (Mandel, Bennet, and Dolin, 2000; U.S. Department of Health and Human 
Service, NIH, 2003 and Seattle and King County Public Health Department, 2005) 
 
Figure A.1  Methods and types of immunization used today: 
Active via Vaccination   Active via Toxoid   Passive via General Ig    Passive via Specific Ig       
1. Live, attenuated 
organism 
2. Killed organism 
3. Partial 
organism(e.g. 
protein from 
organism) 
Some organisms 
produce toxins. A 
toxoid is a toxin that 
has been treated so 
that it can no longer 
produce disease, but 
still contains the 
proteins needed to 
induce immunity 
Immune Globulin 
Pooled serum from 
healthy people with 
immune factors 
against diseases in 
general. 
Specific immune 
globulin 
Serum derived from 
people who have 
recovered from 
specific diseases, 
such as Tetanus or 
Rabies.  An immune 
fraction, called IgG 
is recovered from 
the serum. 
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Appendix B - Response Form 
Figure B.1 Response Form 
Card Code:______ 
Under these circumstances, I would: 
        Never get                                                                                                  Always get 
        a shot                                                                                                        a shot 
             _______________________________________________ 
 
Card Code:______ 
Under these circumstances, I would: 
Never get                                                                                               Always get 
a shot                                                                                                     a shot 
                     _______________________________________________ 
 
Card Code:______ 
Under these circumstances, I would: 
Never get                                                                                              Always get 
a shot                                                                                                    a shot 
         _______________________________________________ 
 
Card Code:______ 
Under these circumstances, I would: 
Never get                                                                                            Always get 
a shot                                                                                                  a shot 
                     _______________________________________________ 
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Appendix C - Demographics 
 
Age_______ 
 
Gender:   (Circle)     Male    Female 
   
Ethnic group:  _____Caucasian (Non-Hispanic) 
  _____Hispanic (Mexican heritage) 
  _____Hispanic (Caribbean heritage) 
  _____Hispanic (other heritage..specify) 
  _____African American 
   _____(by birth) 
   _____(by immigration) 
  _____Middle Eastern (specify ethnic group)_________________ 
  _____Asian (specify group)_____________________ 
  _____Native American (specify tribe)__________________ 
  _____Other (specify if you wish)______________________ 
 
Occupation:   Healthcare/Medicine (specify)______________________    
  Non-Healthcare (Specify)________________________________ 
 
Do you have children?  Yes   No 
 
If yes, ages and Number: 
  _____0-2 
_____3-5 
_____6-10 
_____11-13 
_____14-18. 
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Does your religion take any position on the use of immunizations? 
 
_____No religious affiliation 
 _____No 
_____Yes: (explain) 
 
Health Risks: 
 
 _____Chronic respiratory disease and/or asthma (specify): 
 _____Chronic renal disease 
 _____Diabetes 
 _____Chronic heart disease: (specify): 
_____Regularly take medication that suppresses the immune system (such as    
          prednisone, or chemotherapy for cancer) 
 _____Have a condition that affects the immune system. 
 _____Other chronic disease (specify):          
 _____Have you ever had a severe neurological disease such as Guilian-Barre`? 
 
Immunization and disease history 
 
Have you had your routine childhood immunizations? Yes  No 
 
When did you last have a tetanus shot? 
  Never had one _____ 
  Less than a year ago: ________ 
  2-4 years ago: ______ 
  5-10 years ago: ______ 
  It’s been so long, I don’t remember: _________ 
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Do you usually get a flu shot 
 
 Nearly every year ______ 
 Sometimes      ______ 
 Seldom/never       ______ 
 
Have you ever been immunized against smallpox?  Yes   No 
If yes, when was the last time? 
 If yes, have you ever had a bad reaction? Yes   No 
 
Have you ever had a bad shot reaction from the flu shot? Yes   No 
If yes, explain  
 
 
 
 
 
Have you ever had a bad shot reaction from the tetanus shot? Yes   No 
If yes, explain 
 
 
 
 
Have you ever had a bad reaction to any immunization?  Yes   No 
If yes, please explain 
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Have you ever had a severe case of the flu? Yes   No 
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Appendix D - Post Experiment Interview 
 
Review the following information from the experiment and describe how you thought 
about the information and made your decision: 
1.  
 
 
There is a 1/1,000 chance of people getting Bacterial Meningitis, if exposed to it. 
 
   The immunization against Bacterial Meningitis is effective in 999/1,000 cases. 
 
   However, there is a 1/1,000 chance of a serious side effect of the shot. 
 
 
Please describe how you thought about the information above: 
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2.  
 
 
There is a 50/1,000 chance of people getting Rachmani’s Hubritis, if exposed to it. 
 
The immunization against Rachmani’s Hubritis is effective in 800/1,000 cases. 
 
   However, there is a 1/1,000 chance of a serious side effect of the shot. 
 
Please describe how you thought about the information above: 
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3. How likely do you think you would be to be exposed to each of the following diseases? 
Bacterial Meningitis 
 
 
            I’d never                                                                                   I’m very likely 
get this disease                                                                          to get this disease 
 
         _______________________________________________ 
 
Casalosis: 
 
I’d never                                                                                   I’m very likely 
get this disease                                                                         to get this disease 
 
 
          _______________________________________________ 
 
Neches River Fever: 
 
I’d never                                                                                   I’m very likely 
get this disease                                                                          to get this disease 
 
 
                       _______________________________________________ 
     
Pneumonia: 
 
I’d never                                                                                   I’m very likely 
get this disease                                                                         to get this disease 
 
 
             _______________________________________________ 
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Verde’s Disease: 
 
I’d never                                                                                    I’m very likely 
get this disease                                                                          to get this disease 
 
          _______________________________________________ 
Black Spot Fever: 
 
I’d never                                                                                   I’m very likely 
get this disease                                                                         to get this disease 
 
                      _______________________________________________ 
Hepatitis B: 
 
I’d never                                                                                    I’m very likely 
get this disease                                                                          to get this disease 
 
          _______________________________________________ 
Appalachian Pharyngitis: 
 
I’d never                                                                                   I’m very likely 
get this disease                                                                          to get this disease 
 
                                                                                                            
________________________________________________ 
 
Fibularosis: 
 
I’d never                                                                                   I’m very likely 
get this disease                                                                         to get this disease 
 
         _______________________________________________ 
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Smallpox: 
 
I’d never                                                                                    I’m very likely 
get this disease                                                                          to get this disease 
 
           _______________________________________________ 
 
Chickenpox: 
 
I’d never                                                                                   I’m very likely 
get this disease                                                                          to get this disease 
 
 
           _______________________________________________ 
 
Pertussis: 
 
I’d never                                                                                   I’m very likely 
 get this disease                                                                         to get this disease 
 
 
            _______________________________________________ 
 
 
Which of these diseases look real to you?  Explain: 
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4. Were the instructions clear?   
If not, what wasn’t clear? 
 
 
 
 
 
 
5.  Would you recommend changes in how this experiment was conducted? 
If so, please elaborate. 
 
 
 
 
 
 
 
6. Was the method of reporting your decision (the response form) understandable and 
usable?  If not, please make suggestions. 
 
 
 
 
 
 
 
 
7.Do you have any additional comments? 
 
  
124
Appendix E - Debrief Statement 
 
 
 Thank you for participating in this experiment.  Your participation provides 
valuable information on how people make decisions in disease and health.  With this 
information, we can make better treatment decisions and medical personnel can discuss 
treatment options with people more effectively. 
 This experiment looks at how a person makes decisions about accepting 
immunizations for disease.  Different people may think about immunization diseases and 
immunizations differently based on their experience.  This study helps us understand the issues 
that should be considered. If we were to conduct an immunization campaign, issues in this study 
would need to be thought about in order to know we were doing the right thing.  In addition to 
immunization, the results of this study may be useful in thinking about how people make other 
healthcare decisions. 
 Psychologists in the field of judgment and decision-making study how people 
consider variables to make a good decision.  One area of decision psychology is dedicated to 
medical and healthcare decisions making.  This study is an example of a medical decision 
making study.   
You may wonder if the information from the experiment was correct. The following up-
to-date information is provided for your review: 
The Following are real diseases.  The actual incidence of these diseases and the 
effectiveness of immunization are included for your information (source: Epidemiology and 
Prevention of Vaccine-Preventable Diseases, 9th Ed.): 
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Meningitis:  This is a bacterial disease. Although the incidence of disease in 18-23 year 
olds in general is only 1.4/100,000, the incidence in college freshmen is 1.9/100,000 and the 
incidence in college freshmen who live in dormitories is 5.1/100,00. 
There is an immunization against bacterial meningitis. The Meningococcal Conjugate 
Vaccine has the ability to effectively protect against this form of meningitis in 98% of the cases. 
Pneumonia: This is a bacterial disease.  There are an estimated 3,000 to 6,000 cases per 
year of this disease in the US.  There is an immunization against this disease.  Although one type 
of vaccine is only about 60-70% effective, the other, Pneumococcal Conjugate Vaccine, is 
estimated to be effective 90% of the time. 
Hepatitis B:  This is a viral disease.  An estimated more than 200 million people are 
chronically (continuously) infected with this virus worldwide.  About 78,000 new infections/year 
are reported in the US.  There is a vaccine to prevent infection with this disease.  It is 80%-100% 
effective in preventing infection. 
Pertussis: This is a bacterial disease also called “Whooping Cough”.  It is highly 
contagious.  The incidence of this disease has been increasing since the 1980s.  in 2004, about 
60% of cases were among those 11 or older.  There is a vaccine against pertussis, which is 70%-
90% effective. 
Chickenpox: This is a viral disease.  It is highly contagious.  It is estimated that people 
who have never had the disease and never been vaccinated are 90% likely to get the disease, if 
exposed to it.  A vaccine has been developed to prevent this disease.  It is estimated to be 65%-
100% effective in preventing the disease. 
Smallpox:  This is a highly contagious viral disease.  If a person has never been 
vaccinated against this disease and are exposed to it, they are more than 90% likely to get the 
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disease.  No common source cases of smallpox exist, but the disease is one of several likely to be 
used for bioterrorism.  91%-97% of people who have evidence of vaccination are protected 
against the disease for up to 10 years. 
The other diseases in the experiment are based on hypothetical disease probability 
statements.  To our knowledge, you would be unlikely at this time to encounter diseases for 
which there are immunizations and that fit the exact frequency profile of those diseases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
127
Appendix F – Distracter Task 
 
Code B1 
You are a patient in a local hospital.  You have been very ill and had surgery from which 
you are now recovering.  You have several tubes attached including two for intravenous 
administration of medications and fluids and one for draining fluids.  You need assistance to get 
out of bed, but have been able to sit up for a couple of hours each of the last two days.  Your 
nurse today is Ms. Jones.  She comes into your room with some equipment and looks at your arm 
where the intravenous tube enters.  She checks your armband and asks you how you are feeling 
today.  She examines the intravenous equipment.  Ms. Jones tells you that the doctor has ordered 
a new antibiotic for you and she is adding it to your intravenous solution.  She hangs the new bag 
of fluid and adjusts the pump. 
 
How do you judge Ms. Jones’ competence as a nurse?  Make a mark on the line below to 
show how competent you think Ms. Jones is as a nurse: 
 
Worst Nurse         Best Nurse 
I ever met         I ever met 
 
                     _______________________________________________ 
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Code A2 
You are a patient in a local hospital.  You have been very ill and had surgery from which 
you are now recovering.  You have several tubes attached including two for intravenous 
administration of medications and fluids and one for draining fluids.  You need assistance to get 
out of bed, but have been able to sit up for a couple of hours each of the last two days.  Your 
nurse today is Ms. Jones.  She comes into your room with some equipment and looks at your arm 
where the intravenous tube enters.  She checks your armband and asks you how you are feeling 
today.  She examines the intravenous equipment.  Ms. Jones tells you that the doctor has ordered 
a new antibiotic for you and she is adding it to your intravenous solution.  Ms. Jones consults her 
hand held computer before hanging the new bag of medication.  She tells you that she uses the 
computer to ensure that everything is correct and that there are no problems that have been 
overlooked.  She hangs the new bag of fluid and adjusts the pump. 
 
How do you judge Ms. Jones’ competence as a nurse?  Make a mark on the line below to 
show how competent you think Ms. Jones is as a nurse: 
 
Worst Nurse         Best Nurse 
I ever met         I ever met 
 
                     _______________________________________________ 
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Appendix G – Raw Data 
 
Click here for comma separated value file of Raw Data
Codes used for data: 
BM = Bacterial Meningitis 
VD = Verde’s Disease 
FI = Fibrularosis 
CA = Casalosis 
BSF = Black Spot Fever 
SM= Smallpox 
NRF= Neches River Fever 
HB = Hepatitis B 
PE = Pertussis 
PN = Pneumonia 
AP = Applicacian Pharyngitis 
CPX= Chickenpox 
IFZ = Influenza 
HA = Hepatitis A 
TAS = Tarsallsis 
 After each disease name code is the card number associated with it (used as a second 
check that the correct disease information was associated with the score).   
R1 = replicate #1 
R2 = replicate #2 
BGA is the learning control A at beginning of the first pack of cards 
PTA is the learning control A at the end of the second pack of cards 
BGB is the learning control B at the beginning of the first pack of cards 
PTB is the learning control B at the end of the second pack of cards 
BGC is the learning control C at the beginning of the first pack of cards 
PTC is the learning control C at the end of the second pack of cards 
Demographics: 
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 Part = participant random number code (to marry up different hard copy data) 
 Age = participant age 
 Child = Does participant have any children (they actually listed ages and number, but this 
was coded as yes (they do have children) /0 (they don’t have children) 
 Gender: 
  F = Female 
  M = Male 
 Ethnic: 
  Cauc = Caucasian 
  Hisp = Hispanic 
  Middle East = any Middle Eastern ethnic group 
  Chinese = Chinese 
  African = African American 
  NatAmer = Any Native American (American Indian) group 
 Hlthcrx = health care experience, specified (CNsA = Certified Nursing Assistant) 
 Health Risks: 
  Dep = Depression 
  Anx = Anxiety 
  High BP = High blood pressure 
  MS = Multiple Sclerosis 
  GERD = Gastro-esophageal reflux Disease 
  Others are spelled out 
 
